Quarterly Results Calendar — 28 Jul, 2026
Indian listed companies reporting quarterly results — today and over the next two weeks. For each, a recap of last quarter — the reported numbers and, where we have it, what management guided — so you know what to watch when the numbers land.
- Volume growth: About 7-9% for FY26
- Q4 normalization: Q4 should cover most of the Q3 shortfall (Q4 FY26)
- Value growth: May see some correction as raw-material pricing flows through to selling prices (FY26)
- Container glass volume growth: 3-4% (FY27)
- Specialty glass volume growth: 7-10% (FY27)
- Consolidated Volumes: 80 million tons (FY27)
- Volume Growth: 8% (FY27)
- Industry Growth: 5-5.5% (FY27)
- Capacity: 119 million tonnes (End of FY27)
- Cost Reduction: Rs 250 per ton (FY27)
- FY27 Revenue Growth: Better than FY26 (no specific target provided) (FY27)
- Sales Team Expansion: 30-40% increase by mid-FY27 (By mid-FY27)
- Order Booking Focus: Substantially better than FY26 order book (FY27)
- Steady-State EBITDA Margin: 15%+ (down from Q4 18.5%) (FY27 onwards)
- Margin Impact from Sales Investment: Erosion from current levels as sales team and capability investments ramp (FY27)
- FY27 revenue growth: At least 25% more than this year (FY27)
- Medium-term revenue growth: 20-25% growth (Next 1-3 years)
- EBITDA margin: Around 10.5% (FY27 and beyond)
- EBITDA margin floor: More than 10% (Near term)
- New order target: Rs 25,000 Cr (FY27)
- Operating margin: 7-10% (FY27 / near term)
- Earlier operating margin range: 6-8% (prior call baseline)
- FY27 capex: Over Rs 100 Cr (FY27)
- PTCF commercial sales: Start in FY27 H2
- Additional capacity: About 2-2.5 kt (FY27 project commissioning)
- Crop business: Will be participating in the crop business across the states and therefore what was lost will definitely we certainly hope to get it back in the crop site and since had a good experience over the years on the direct side of crop business we should be looking at even growing that piece of business (Next tender cycle)
- Motor OD loss ratio: Reduction (Next six months)
- Price realization on OD side: 7-8% improvement (Last two to three months)
- ROE: 15%+ (Medium to long term)
- Combined ratio: Significant drop (Year of adoption (FY28))
- Advance growth over industry: 2.3% above industry credit growth (FY27)
- MSME share of advances: 55-60% (FY27)
- Gold-loan share of advances: 30-35% (FY27)
- Third-party business share: 1-2% (FY27)
- Branches added: 75 branches (FY27)
- PVC price range: Rs 80-82/kg should stay somewhat stable, though it may soften a little (near term)
- Import duty on PVC: 11% duty hoped to return from 1 July 2026
- MIP / ADD on PVC: A realistic MIP and a renewed ADD review remain on the agenda (next few weeks to months)
- Current ECU: Rs 32,000-33,000 per metric ton (excluding flakes) and expected to remain balanced (medium term)
- Capacity utilization: Capacity utilization should stay robust in the coming year (FY27)
- Revenue growth: >30-35% (FY27)
- Revenue growth: similar growth (FY28)
- PEC annual revenue: ~Rs 150 Cr (FY27/FY28 annual run-rate)
- Ramp-up timing: 2-3 month delay; contribution from next financial year onward (FY27)
- EBITDA margin: 46%-48% (near term)
- Net Interest Margin: 7% give or take a few bps (ongoing / FY27)
- Cost of funds: upward trend after March deposit repricing (FY27)
- Credit-deposit ratio: slightly below 90% (FY27 exit)
- Return on assets: 1.2% to 1.25% (FY27 full year)
- Exit ROA: about 1.5% (Q4 FY27 exit)
- Revenue growth: FY27 to be better than FY26
- EBITDA margin: around 22.5-23.5% (medium term)
- Pricing action: 2-5% already taken; further increases as needed (current to FY27)
- Rainfall impact threshold: No rural demand impact expected unless rainfall falls below 85% (H2 FY27)
- Planned capex investment: Rs 2,000 Cr (near term)
HLV Limited's most recent reported quarterly results are for Q4 FY26 (quarter ended March 31, 2026). In the quarter ended March 31, 2026, HLV reported the following standalone financial results: Revenue: Rs 63.45 Crores.
- Home Appliances Division Revenue CAGR: 20%+ over 3 years (FY26-FY28)
- AC Market Share: 3% to 6% (FY26)
- Appliances Division EBITDA Margin: Double-digit (10%+) (FY26-FY27)
- Material Cost Savings: Rs 79 Cr full-year (Rs 44 Cr Q4) (FY26)
- Logistics Cost Control: Rs 150-175 Cr reduction target (FY26-FY27)
Indian Toners (INDTONER) reported standalone revenue of Rs 45.74 Crores for Q4 FY26, representing an 8.6% sequential growth and a 12.4% year-over-year increase. Margin Expansion: The company improved its operational efficiency in Q4 FY26, with EBITDA margins expanding by 1.0 percentage point sequentially to 25.2%.
- Europe revenue trend: Continue to grow (FY27/FY28)
- US portfolio mix: Solid orals and liquid orals to support growth (FY27/FY28)
- Emerging markets visibility: High confidence for next 2-3 years
- India seasonal recovery: Muted Q4 should normalize when season returns (next 1-2 quarters)
- Europe margin: Better margins in the coming year (FY27)
- Group revenue growth: 15% (FY26)
- Order inflow growth: exceed 10% (FY26)
- Projects and manufacturing EBITDA margin: 8.5% (FY26)
- Hydrocarbon margin trend: Soft for the next 2-3 quarters, then recovery as legacy jobs close
- Net working capital to revenue ratio: around 10% (March 2026)
- Publication revenue growth: 15% growth in a single year (FY27-FY29, first 2 years)
- Domestic stationery revenue growth: 15% growth (Subsequent year)
- Export stationery revenue growth: 8-9% higher single-digit growth (FY27)
- Stationery EBIT margin: 9% (Current year)
- Stationery EBIT margin: 9.5-10% (Next year)
- Revenue growth: 35-40% (next 2 years)
- Organic revenue growth: about 35% (FY27 base business)
- Operating EBITDA margin: 13-14% (next 2 years)
- Strategic order execution window: next 3 quarters (FY27)
- Strategic order inclusion in guidance: excluded from the 35% organic growth base (FY27)
- Demand visibility: Optimistic for fertilizer demand; Q1 and Q2 raw-material coverage largely secured (Q1-Q2 FY27)
- Product mix: Higher share of NPK and DAP versus sulfur-intensive products (FY27)
- EBITDA per ton: Around Rs 5,300/ton at the company level; backward integration should lift spreads in FY27
- Urea EBITDA uplift: About Rs 1,200/ton in the current gas-price scenario from Goa energy efficiency (Current gas-price scenario / FY27)
- FY27 capex: Around Rs 600 Cr (FY27)
- Revenue growth: 21-23.5% (FY27)
- Quarterly phasing: Q1 at the lower end of guidance; Q2-Q4 improve (FY27)
- Middle East and airline softness: Softness already incorporated into FY27 plan
- Contribution margin: 74-75% (FY27)
- Contribution margin variance: 2-3% swing possible from mix (FY27)
- Disbursements minus prepayments: 30-50% growth (future / FY27 onward)
- FY27 disbursement target: not yet set; budget under approval (FY27)
- Cost of borrowing: expected to decline as fresh borrowing replaces older liabilities (future)
- PFS BR: further decline expected (future)
- Fresh slippages: none expected from the recent disbursement book (future)
- Prestige & Above volume growth: 20% (FY27)
- Luxury portfolio sales value growth: 25% (FY27)
- EBITDA margin expansion: 125 bps (FY27)
- A&P as % of revenue: 6%-8% (FY27)
- Regular volume growth: 3%-5% (FY27)
- FY27 revenue growth: similar kind of growth as FY26 (FY27)
- Revenue mix: 50% aerospace and defense / 50% non aerospace and defense (FY27)
- Semiconductor and space revenue growth: 300% to 400% growth (FY27)
- Margin range for current competencies: 17% to 22% (FY27 and beyond)
- MRO margin profile: much higher than current competencies (FY27 onward)
- Domestic formulations growth: ~12% historical trajectory (medium term)
- API growth: 9%-10% historical trajectory (medium term)
- International formulations growth: return to growth after inventory rationalization (FY27 onward)
- API margin: around 30% (near term)
- Other expenses: normalize from the Q4 expiry spike (next quarter onwards)
Sanofi Consumer Healthcare India Ltd.'s most recent reported quarterly results are for Q4 FY26. The company has not yet released results for the quarter ended June 30, 2026 (Q1 FY27), which are scheduled for approval on July 28, 2026.
- ISG motorcycles: 3 popular motorcycle models in the top 10 sold in India (FY27)
- Launch timing: 2 launches in Q1; 1 launch in Q4 (FY27)
- Export 3W ISG: Ramp-up continues after Q4 SOP (FY27)
- MF3 scale: 3x the size of the current mother plant (FY27 onward)
- MF4 shipments: Electric-machine shipments start from Q3 (FY27)
- Adjusted EBITDA margin: Maintain at current level in H1 FY27; keep above 12-13% floor
- Gross margin: Around 42% and thereabout (H1 FY27)
- EBITDA: Rs 300+ Cr (FY27)
- Capex: Rs 140 Cr (FY27)
- Vanavate commissioning: Coming months (FY27)
- Revenue growth: 25-30% (FY27)
- Revenue target: Rs 1,000 Cr (FY29)
- EBITDA margin: 19-21% (FY27)
- Capex: Rs 5-6 Cr (FY27)
- Commercial production of acrylic/polyester products in India: Q1 FY27
- Plastic piping volume growth: 15-17% (FY27)
- Overall volume growth: 12-13% (FY27)
- Plastic piping industry growth: 8% (FY27)
- Operating margin: 14-14.5% (FY27)
- Return on average capital employed: >25% sustainable (ongoing)
- Industry wind installations: 8-9 GW (FY27)
- Near-term wind installations: 10 GW (near term)
- 5-year wind installations: 15 GW (next 5 years)
- WTG margin: around 22% (FY27)
- OMS margin: around 67% (FY27)
- AUM growth: 23-25% (FY27)
- Housing finance AUM growth: similar pace to FY26 (about 29%) (FY27)
- Cost of funds: lower than FY26 (FY27)
- Operating costs: down about 15 bps (FY27)
- Motor finance growth: growth resumes (1H FY27)
- Phoenix Market City Pune rental income: 14-15% increase (FY27)
- Phoenix Market City Bangalore rental income: about 20% increase (FY27)
- Retail portfolio rental growth: strong double-digit growth (FY27)
- Portfolio area coming up for renewal: 36-50% over the next 2-3 years (FY27-FY29)
- April consumption growth: close to 30% (April FY27)
- Ethanol blending target: 21% blending already notified; higher blending roadmap under discussion (current / near term)
- Incremental ethanol demand per 1% blending: 55-56 crore litres (per 1% increase)
- FY27 gross ethanol sales target: 55 crore litres (FY27)
- Additional CBG plants: 9 plants (3 Sumitomo, 6 GAIL) (next 9 months)
- Gross CBG capacity: 162 tonnes per day (by end FY27)
- Appliances revenue growth: around 10% (near term)
- Kitchenware revenue growth: around 10% (near term)
- Induction cooktop adoption: robust for a couple of more quarters (next 2 quarters)
- Export growth: 20-22% on a smaller scale (ongoing)
- Input cost inflation: around 10% (current run-rate)
- Volume Support: Higher volumes expected from stabilized greenfield plants (Upcoming Season)
- Operating Leverage: Expected to improve as facilities stabilize (CY2026)
- Generation Assets Commissioning: 1.5 GW (FY27)
- Battery Capacity Commissioning: 10 GWh (FY27)
- Battery Capacity on Merchant Basis: 8.5 GWh (FY27)
- Battery Capacity on FDRE Format: 1.5 GWh (FY27)
- EBITDA Margin for Merchant BESS: 75-80% (Ongoing)
- Incremental EBITDA: over 3,000 crore (next fiscal year)
- Total EBITDA from Navi Mumbai Airport, Ganga Expressway, and Copper: 6,000 to 6,800 cr (FY28 (peak capacity))
- Dispatch volume growth: high double digit (close to 20%) (next year)
- Total CAPEX: around 40,000 crore (next year)
- Airport CAPEX: about 17,000 crore (next year)
- Revenue growth: 1.5x India growth (FY27)
- Revenue growth upside: 1.7x-1.8x India growth without acquisitions (FY27 and beyond)
- Revenue CAGR: 18%-19% (next 5 years)
- EBITDA Margin: 70% and above (next 5-6 years)
- Cost per ton: flat (next 5-6 years)
- Consolidated Revenue FY27: Rs 925–1,000 Cr (base case) or Rs 800–850 Cr (if Middle East offline) (FY27)
- Ashoka brand revenue growth: 30–35% YoY growth (FY27)
- Truly Indian brand revenue: Rs 75–80 Cr (FY27)
- Surat facility revenue contribution: Rs 40–50 Cr (FY27)
- Soul brand domestic revenue: Rs 100 Cr (Within 3 years)
- Consolidated revenue growth: 45-50% (FY27)
- Operational EBITDA growth: approximately 2x (FY27)
- Aerospace revenue growth: 25-30% (FY27)
- Aerospace EBITDA margin: around 20% (FY27)
- Consumer revenue growth: about 125% (FY27)
- Volume growth: low double digits (FY27)
- Revenue growth: not quantified; depends on raw-material prices and realizations (FY27)
- EBITDA margin: better than the average of last year (FY27)
- Nitrile latex margin: continued improvement toward base-business levels (next few quarters)
- Major capacity expansion: none in FY27
- Volume growth: 8-10% (next few quarters / FY27)
- EBITDA margin / PBDIT margin: 18-20% (FY26 / FY27)
- Price increase already taken: 10.5-11% (Q1 FY26 run-rate)
- Residual cost impact not yet passed through: ~20% (current inflation cycle)
- VAE/VAM commissioning: H1 FY26
- Portfolio yield: Broadly sideways in Q1 FY27; slight compression possible through FY27 (Q1 FY27 / FY27)
- Net interest margin: Some contraction through FY27, partly offset by opex efficiency and lower loan losses
- Cost of funds: 2-3 bps reduction in Q1 FY27; marginally sideways thereafter unless money markets normalize
- Borrowing structure: Keep borrowings diversified; fixed issuance can be synthetically converted to floating via OIS (FY27)
- ROA: Upper end of the 2.0-2.2% medium-term range (Medium term)
- OHT volume guidance: No formal guidance; growth expected (FY27)
- US volume share: 10% of volume (FY27)
- Price hikes: 3-5% already taken across geographies (Current quarter)
- Second-round price hike: Planned by month-end (Current month)
- Raw-material basket inflation: 7-8% increase expected (June quarter)
- Revenue growth: Short-term drag expected from West Asia conflict and suspended OMC loyalty programs; no structural change to the long-term profile (Near term)
- Retention / ARPU: Long-term retention and ARPU expected to remain consistent (Long term)
- Adjusted EBITDA margin: Combined margin may remain around current levels as growth businesses absorb investment (FY27)
- Core profitability: Core businesses continue to compound profitability through operating leverage (FY27)
- Vehicle finance business: Expected to exit investment mode by FY26 end and start churning cash flows (By end-FY26)
- Elite Buyer & Verification revenue contribution: Expected to become significant from Q1 FY27; could reach 30-40% of OLX revenue within 3 years (FY27 onwards; 3-year horizon)
- OLX overall growth trajectory: Expect momentum to step up immediately from new product launches (Q1 FY27 onwards)
- EBITDA margins across Consumer, Remarketing, OLX: Expected to expand further; already at 39%, 28%, 33% respectively in Q4 FY26 (FY27 onwards)
- Consolidated PAT target: ~Rs 1,000 Cr (4-5 years from FY26)
- Car industry growth: Grew ~20% in April; GST tax reduction expected to sustain growth for next 1-3 years (FY27-FY28)
- Planned Capex (FY27-FY29): Approximately Rs 30 billion (FY27-FY29)
- Capex Funding Source: Largely through internal accruals (FY27-FY29)
- Total Room Inventory: Over 5,000 keys (3,389 operating + 1,655 pipeline) (Current)
- Monthly Rental Exit Run-Rate: Rs 280 million (March 2026); expected to scale to Rs 300 million during FY27
- CRE Portfolio Committed Occupancy: Approximately 88% (Current)
- Revenue growth: mid-teens (FY27)
- Top-line sensitivity to aluminium prices: current aluminium price levels assumed (FY27)
- Powertrain stationary-engine revenue: $100 million (FY29-FY30)
- Phase 2 powertrain expansion: possible after September order review (post-September)
- Aluminium business revenue: $1 billion (2-3 years)
- India FMCG growth: High-single to low-double-digit growth (FY27)
- Growth mix: Roughly 50% volume and 50% price contribution (FY27)
- Operating margin: Sequential improvement in Q1 and y/y improvement in FY27 (Q1 FY27 to FY27)
- Pricing action: 4% price increase already taken; second round may follow if inflation persists (Q1 FY27 to FY27)
- A&P intensity: Advertising stays flexible; margins take priority over media if inflation remains high (FY27)
- Net new stores: 200-225 stores (FY27)
- KFC net new stores: 110-120 stores (FY27)
- Portfolio mix for additions: Costa Coffee, Biryani by Kilo and international businesses to drive the balance of additions (FY27)
- Net new Pizza Hut stores: 0 net new stores (Calendar 2026)
- Pizza Hut relaunch: Back-to-basics strategy to launch in a couple of months (Next few months)
- Leasing seat additions: 18,000-20,000 seats per year (FY27)
- Design & Build revenue growth: ~40% (FY27)
- Furniture revenue growth: >50% (FY27)
- Average rent per seat: Rs 7,250-7,500 per seat (FY27)
- Center-level EBITDA margin: 30%+ (FY27)
- Royal Enfield interim capacity: 1.6 million units by June/July 2026 (FY27)
- Royal Enfield long-term capacity: 2.0 million units by Q2 FY28
- Andhra Pradesh greenfield lead time: 24-30 months from land signing to plant commissioning (medium term)
- Commodity inflation impact: 3-3.5% on middle-cost level (Q1 FY27 / FY27)
- Price increase: 1.75% in April 2026 (Q1 FY27)
- Organic revenue growth: 18% (FY27)
- US product segment growth: 25-30% (next year)
- Enterprise product segment growth: 25-30% (FY27)
- PAT growth: 25-30% (FY27)
- Bottom-line growth: 27-28% (FY27)
- Domestic formulations revenue growth: 1.3x covered-market growth (FY27)
- Covered market growth: double digit (FY27)
- Domestic formulations EBITDA margin: 37% (FY27)
- Consolidated EBITDA margin: 36% (FY27)
- H1 vs H2 margin profile: H1 softer than H2 (FY27)
- NGC revenue booking: latter half of FY28
- NGC revenue generation: second half of FY28
- Margin level: around 9-10% (FY28-FY29)
- Margin maintenance: similar margins (FY28-FY29)
- Export segment opportunity: opportunity in the next 1-2 years
- Central India cement demand growth: 7-7.5% (FY27 / FY28)
- Company volume growth: in line with industry growth (FY27 / FY28)
- Near-term cost inflation: Rs 100-160/tonne (next quarter / H1 FY27)
- Pricing recovery: cost increases to be passed on (next quarter / H1 FY27)
- FY27 capex: Rs 100 crore (FY27)
- CY26 revenue growth vs CY25: better than 7.6% (CY26)
- Renewal scope impact from AI: 20-40% lower for the same scope (FY26 renewals)
- EBIT margin: 13-14% (CY26)
- H2 exit margin: better than the current year (H2 CY26)
- Q1 growth: weaker than seasonal (Q1 CY26)
- Revenue growth floor: 7.6% (FY26)
- Growth cadence: Sustained growth from Q2 onward (Q2-Q4 FY26)
- EBIT margin: 13-14% (FY26)
- Exit rate margin: Higher than full-year average (H2 FY26)
- Q4 seasonality: Q4 weaker than Q2/Q3 (FY26)
- Disbursement CAGR: 35% (through FY29)
- Profit after tax: 450-500 Cr (FY29)
- Loan book size: 16,000-17,000 Cr (FY29)
- Branch additions: about 100 branches (next 3 years)
- Portfolio-level productivity gains: 10%-15% (next 3 years)
- Top-line growth: 18-20% (FY27)
- PAT growth: 20-22% (FY27)
- Gross margin: around 10% (short term)
- Incremental gross margin conversion to EBITDA: >70% (next 2-3 years)
- GCP order book: INR 300+ crore (FY26-FY30)
- Revenue growth: 12-15% (FY27)
- Growth vs IPM: 1.5x IPM (FY27)
- New product launches: 9-10 launches (current year)
- Breakthrough molecule announcement: May end / June first week (current year)
- New product contribution to growth: 3%+ (FY27)
- Cement demand growth: about 6% (FY26-FY27)
- FY26 volume growth: 5.5%-6.5% (FY26)
- Energy cost increase: at least Rs 300/ton (coming quarters)
- Packaging cost increase: Rs 80-100/ton (coming quarters)
- Q1 cost hit: Rs 100-130/ton (Q1 FY27)
- Steel consumption growth: High single-digit growth (FY26)
- Demand trajectory: Sustain and potentially accelerate (medium term)
- Royalty realization per metric ton: Increase 10-15% every year (annual)
- Royalty income contribution: Larger share of overall earnings over the coming years (FY27 and beyond)
- Franchisee volume growth: Around 10% every year (near term / annual)
- Revenue growth: highest growth quarter of FY26; positive organic growth (Q4 FY26)
- Profitability: above Q3 despite investment (Q4 FY26)
- Revenue growth: higher than FY26 (FY27)
- EBITDA margin: similar margins despite continued investment, with midterm improvement (FY26-FY27)
- Solution conversion: 12-18 months for broad conversion; 3-4 months for some AI wins (next 12-18 months)
- Dahej revenue contribution: H2 FY27
- Ramp-up trajectory: Gradual ramp into FY28 and beyond (FY28+)
- Dahej Phase 2 chemical charging: Q1 FY27
- Sampling to customers: Q1 FY27
- World-scale ethyl acetate dispatches: Already started; ramp ongoing (FY27)
- AUM growth: 20-25% (medium term)
- AUM target: Rs 1 lakh Cr (2036)
- Housing finance AUM growth: 30-35% (FY27 onward)
- Housing finance AUM: Rs 1,000 Cr (next quarter)
- Average cost of borrowing: 9.20-9.25% (next 2-3 quarters)
- Overall revenue: Better revenue (FY27)
- Overall profitability: Better profitability (FY27)
- Crop Protection top-line growth: Double-digit growth (FY27)
- Crop Protection EBITDA margin: 15%-17% (FY27 / long term)
- Crop Nutrition revenue growth: Good growth in the current financial year (FY27)
- FY26 production target: 23.5 lakh tonnes (FY26)
- FY26 year-end production: 19-20 lakh tonnes (FY26)
- FY27 production target: 25 lakh tonnes (FY27)
- Balaghat current production: 3.5 lakh tonnes (current)
- Balaghat eventual capacity: 8 lakh tonnes (5-6 years)
- Revenue growth: 80%±5% (FY27)
- Clean energy revenue mix: ~70% of revenue (FY27)
- EBITDA margin: ~24% (FY27)
- Capex: Rs 250-300 Cr (next 2 years)
- Oil & gas plant commissioning: by September (FY27)
- Carbon black volume growth: High single-digit growth (FY27)
- Carbon black EBITDA growth: More than double-digit growth (FY27)
- Carbon black EBITDA per ton: 14-15% increase from the 14,900 odd per ton base (FY27)
- Aquapharm top-line growth: 20-25% (FY27)
- Aquapharm EBITDA per quarter: Rs 50-55 Cr (FY27)
- Revenue growth: early to mid teens (FY27)
- Revenue phasing: H2 weighted; growth builds from Q2 onwards (FY27)
- Destocked product contribution: excluded from FY27 outlook
- EBITDA growth: faster than revenue growth (FY27)
- PAT trend: meaningful improvement (FY27)
- Revenue growth: 25-30% (FY27-FY28)
- Same-store sales growth: 25-30% (FY27-FY28)
- Revenue driver mix: Major turnover from SIS plus upcoming stores (next 2 years)
- EBITDA margin: 19-23% (long term)
- Gross margin: May improve as brand value gets loaded (medium term)
- Pre-sales growth: 15-20% (FY27)
- Collections growth: 15-20% (FY27)
- Quarterly GDV launches: ₹5,000 Cr (current quarter / near term)
- FY27 remaining launch pipeline: ₹57,000 Cr GDV (rest of FY27)
- FY27 FY-to-date launches: ₹14,000 Cr GDV (current quarter plan)
- Consolidated EBITDA margin: 2%+ in the immediate term (FY27 near term)
- Consolidated EBITDA margin: 2.4% in the medium term (next 3 years)
- Professional staffing EBITDA margin: 11-12% (medium term)
- Overseas EBITDA margin: 6%+ (medium term)
- Professional staffing headcount growth: 10-11% (next couple of years)
- India revenue growth: Continued strong momentum; some softness expected Q1 FY27 due to seasonality
- Middle East revenue growth: Softness in Q1-Q2 FY27 due to West Asia crisis; recovery expected post-crisis resolution
- Africa revenue growth: Continued strong growth; SSG and TSG to lead (FY27)
- SSG revenue growth: Sustain growth at or above 30% YoY; cloud and AI agents ramping (FY27)
- Large deals pipeline: Robust pipeline; data center market in India growing from 1.5 GW to 7.5 GW (FY27-FY28)
- Ash & coal handling growth: Same growth as FY26; double-digit growth in ash and coal handling. (FY27)
- Consolidated growth: Higher percentage growth than FY26 as wind scales from a small base. (FY27)
- Wind order book execution: Complete open Rs 1,500 Cr book in FY27.
- Wind capacity: 2 GW by next year-end.
- Consolidated EBITDA margin: 15-18% EBITDA band; 20.1% Q4 margin is sustainable. (FY27)
- Revenue Growth: 10-15% (FY27)
- Volume Growth: around 15% (FY27)
- Gross Margins: around 35% plus or minus a few percent (FY27)
- EBITDA Margins: 18-20% (FY27)
- Non-Agrochemical Business Growth: 5-10% (FY27)
- Revenue: Rs 1,000 Cr (2030)
- Powder revenue growth: Small increase; no huge jump (FY27)
- Layer bird capacity: 40 lakh birds (By 2029)
- Egg powder capacity: 10,000 MT (Over 5 years)
- Project completion: 2028/29 (FY29)
- Annual price increase across products: Continue annual price increases across all products (going forward)
- Book repricing coverage: Reprice almost 80% of the book between Q4 and Q1 (Q4 FY26 to Q1 FY27)
- Combined ratio target: Maintain the target combined ratio (FY27 onward)
- GWP growth: Sustainable high-teens growth (medium term)
- ROE: Sustainable mid-teens to high-teens ROEs (medium term)
- FY27 volume growth: 20%+ (FY27)
- 3-year CAGR: 20%+ (FY27-FY29)
- Sales doubling: Double sales vs FY26 (FY29)
- PAT: >Rs 100 Cr (FY27)
- EBITDA margin: 25-26% sustainable level (going forward)
- Revenue from operations: Sequential improvement in H2 FY26
- Export activity: Pick up from this quarter and build over the medium term (Q3 FY26 onward)
- EBITDA margin: Improvement from current level (H2 FY26)
- Profitability: Improve from here on (H2 FY26)
- Maize procurement price: Rs 19-20/kg range (Next couple of quarters)
- FY27 revenue performance: broadly flat (FY27)
- H2 vs H1 revenue mix: H2 FY27 meaningfully stronger than H1
- Growth profile: growth weighted to the second half (FY27)
- EBITDA margin: mid-20s (FY27)
- Librella revenue: almost no Librella in Q1 FY27 and Q2 FY27 (H1 FY27)
- Revenue growth: 30-35% (FY27)
- Export revenue: Rs 1,500 Cr+ (FY27)
- Operating EBITDA margin: 10-10.5% (FY27)
- Total EBITDA: Rs 700 Cr (FY27)
- Organic capex: Rs 100-150 Cr (FY27)
- Q1 FY27 GTV / GP growth: higher YoY and QoQ versus Q4 FY26 (Q1 FY27)
- Business growth aspiration: early-to-mid 20s (medium term)
- SG&A growth: will slightly taper down (FY27)
- Top-line vs SG&A growth gap: top line should grow faster than SG&A (FY27)
- Operating leverage: green shoots should show up in Q1 FY27
- Headcount: positive headcount by end-H1 FY27
- Open positions: about 20,000 open positions at FY27 entry (FY27 opening)
- Revenue outlook: positive demand backdrop; no formal numeric revenue guidance (FY27)
- EBITDA growth: over 20% (FY27)
- Margin trajectory: soft for the next 2-3 quarters, with a bounce-back thereafter (Q1-Q3 FY27)
- Credit growth: 12% (FY27)
- Deposit growth: 10% (FY27)
- Business growth versus system: Above system growth if the system grows 16% (FY27)
- Net Interest Margin: Around 3.5% (FY27)
- CASA ratio: 45% (FY27)
- Overall business growth: around 15% (FY27)
- Deposit growth: 10-15% (FY27)
- Advances growth: 15-20% (FY27)
- Net interest margin: 3%+ (FY27)
- Return on assets: 1%+ (FY27)
- Domestic sugar production: 27.8 million metric tonnes (Season 2025-26)
- Company sugar consumption: 27.5 million metric tonnes (Season 2025-26)
- Sugar exports: just above 0.5 million metric tonnes (Season 2025-26)
- Closing sugar stock: 4.6-4.8 million metric tonnes (Season 2025-26)
- Refined sugar price: around Rs 4,220/MT (Current / near term)
- Demand: Highly robust (FY27)
- Capacity utilization: Full utilization of both Dahej and Roha facilities (FY27)
- High-value product mix: 10-12% in FY27, potentially higher on pending approvals
- Manufacturing EBITDA margin: Close to 24-25% on manufactured sales (FY27 / current run-rate)
- CoatIcon capex: Rs 5-12 Cr (FY27)
- Company volume growth: 15% (FY27)
- ATBS volume growth: 15-20% (FY27)
- IB and HP MTBE growth: double-digit growth (FY27)
- Butyl Snow growth: moderate growth (FY27)
- New products in pipeline: 2-3 products (H2 FY27)
- FY27 capacity utilization: 95% (FY27)
- FY27 production volume: 10,200-10,400 MT (FY27)
- Q2 FY27 sales volume: 2,300-2,400 MT (Q2 FY27)
- FY28 total production volume: 13,600-13,700 MT (FY28)
- FY29-30 total production volume: 15,500 MT (FY29-30)
- EBITDA: INR 5,500 - 6,000 Cr (FY26)
- US Module Capacity: 4.2 GW (Mid-CY2026)
- Indian Cell Capacity: 5.4 GW (Operational) (Current)
- Q1 FY27 revenue trajectory: No degrowth expected as of today (Q1 FY27)
- Mega-deal revenue contribution: Some revenue in Q1, more in Q2, full-fledged revenue from Q3 (Q1-Q3 FY27)
- FY27 performance dependency: Performance contingent on mega-deal execution (FY27)
- Margin guidance: Mid-teens (FY27)
- Transition-cost pressure: Pressure in Q1 and Q2 until revenue starts and transition phases over (Q1-Q2 FY27)
- Capex: Rs 700-800 crore (FY27)
- Initial Revenue Accrual: Q2 FY27
- Net Debt: Decline (FY27)
- Tax Rate: 10-15% (FY27)
- Total Revenue Growth: 16-18% (FY27)
- US Generics Growth: mid-single-digit (FY27)
- Asia Branded Generics Growth: high double-digit (FY27)
- Africa Branded Generics Growth: high double-digit (FY27)
- India Business Growth: mid-teens (FY27)
- Revenue growth: High single-digit (FY27)
- Non-GPL growth momentum: Sustain current momentum (FY27)
- EBITDA margin: 30-32% (Going forward / FY27)
- EBITDA margin floor: Above 30% (FY27)
- Capex: About Rs 540 Cr (FY27)
- Revenue growth: high single-digit (FY27)
- Non-GPL contribution: continue to increase (going forward)
- EBITDA margin: 30%-32% (going forward / FY27)
- R&D spend as % of sales: around 4% (next 1-2 years)
- Capex: Rs 540 Cr (FY27)
- FY27 revenue: Rs 380-400 Cr (FY27)
- FY28 revenue: Rs 700-800 Cr (FY28)
- 3-year revenue CAGR: ~30% (next 3 years)
- EBITDA margin: 25-30% (FY27- FY29)
- Consolidated EBITDA margin: 24-25% (near term)
- Q1 FY27 Revenue: 400 crore+ (Q1 FY27)
- FY31 Revenue: 5000 crores (FY31)
- Revenue CAGR: 35% (next 5 years)
- Apollo Standalone EBITDA per ton: 8,000 to 10,000 rupees (regular basis)
- Kisan Mouldings EBITDA per ton: 5,000-6,000 rupees (sustainable basis)
- Bromine annual production: 20-21k MT (55 MT/day sustained run-rate) (FY27)
- Bromine pricing trajectory: Majority of long-term contracts renegotiated upward post-Iran crisis (FY27 onwards)
- Bromine next production milestone: 25k MT (intermediate target), then 40k MT (long-term with derivatives scaling) (Multi-year)
- Industrial salt growth target: 10-12% annual growth (historical rate) (FY27 onwards)
- Salt logistics cost normalization: Road construction in Kutch to complete by early Q3 FY27; normal transport distance and costs resume
- Food volumes growth: double digit, at least mid-teens (FY27)
- Food business EBITDA: neutral (till FY27)
- Alternate channel volume contribution: 30-35% (years to come)
- EBITDA per ton: around ₹3,600 (steady state)
- AUM growth: 20-24% (FY27)
- New customer additions: 15-17 million (FY27)
- Gold loan share of AUM: >5% (FY27)
- Credit cost to average AUM: 145-160 bps (FY27)
- GNPA / NNPA: range bound within long-term guidance (FY27)
- Revenue from operations: better year-on-year in FY27
- Deferred March sales: Rs 50-70 Cr to flow into Q1 FY27
- Q1 FY27 top line: better than Q4 FY26 (Q1 FY27)
- Branded EBITDA margin: 18-20% (next year / FY27)
- B2B EBITDA margin: around 8% (next year / FY27)
- TAN production: About 16,000-17,000 tons over 9 months (FY27)
- TAN revenue per ton: Rs 37,000-38,000 per ton (FY27)
- Urea sales volume: Better than last year; 3.5 LMT is touch-and-go (FY27)
- Complex fertilizer availability: Constrained near term; July-August stock cover already secured (FY27)
- Gas cost: Around 18-18.5 (Q1 FY27)
- Revenue growth: around 20%-25% (short term)
- EBITDA margin: 38%-40% (short term)
- Additional order book: about Rs 1,900 Cr (next 12 months)
- Negotiated order conversion: 1-2 months for several contracts (next 1-2 months)
- Program delivery window: few months to 3 years depending on contract (ongoing)
- Gopalpur TAN utilization: 90-95% by FY27-end
- Gopalpur TAN capacity utilization: Full / near-full utilization next year (FY28)
- Dahej nitric acid commissioning: Q2 FY27
- FY27 capex: Rs 800-1,000 Cr including maintenance (FY27)
- IPA prices: Remain elevated for some time (Next few months)
- Core business growth: High single-digit to double-digit growth potential (FY27)
- Export revenue share: Potential recovery from 5% toward the 8% level seen a couple of years ago (Medium term)
- Export outlook: Uncertainty likely to persist through H1 FY27
- Price hikes: Further increases likely if commodity inflation remains elevated (FY27)
- EBITDA margin: 11.7% sequentially maintained in Q4 FY26
- Top-line visibility: No good guideline; top line likely remains range-bound near current levels (near term)
- Product pricing: +Rs 8-12/kg possible (when demand returns)
- Profitability spread: Almost beta-neutral (current)
- Margin outlook: Steady state (near term)
- Recycling project start: Start by end-September (FY27)
- EBITDA margin: 14-15% normalized (long term)
- EBITDA margin: 16-18% after vertical integration (normalized post-integration)
- EBITDA margin: 15-16% long term; 18-20% with vertical integration
- ROCE: 8-10% (FY27-FY29)
- Q4 revenue: similar to Q3 (Q4 FY26)
- Additional beds across existing hospitals: about 500 beds (next 12 months)
- Beds through greenfield projects: about 2,700 beds (next 3-4 years)
- Total project capex: about Rs 45,000 million (next 5 years)
- FY27 capex: Rs 800-900 crore (FY27)
- FY28 capex: Rs 600-700 crore (FY28)
- Revenue growth: ~25% (FY27)
- PAT margin expansion: at least 50 bps (FY27)
- EBITDA margin: about 11.5% or thereabouts (FY27)
- Inventory: elevated levels to continue (near term / FY27)
- Debtor days: around 40-45 days (near term)
- Same-store sales growth (SSSG): Positive full-year SSSG by end of FY27
- Revenue growth: No FY27 degrowth; growth expected
- Square footage growth: At least 10%-11% increase (FY27)
- Net store additions: 10-15 stores; net guidance remains difficult because closures and openings offset each other (FY27)
- Store format: 700+ sq ft format as the standard (FY27)
- Animal healthcare revenue: Recovery from this quarter onwards (FY27)
- Poultry healthcare revenue: Sustain the current trend / base (FY27)
- EBITDA / margin discipline: Continue the current bottom-line focus and sustain the base (FY27)
- Price actions: Calibrate price actions wherever required (FY27)
- Fresh capex: No definitive answer; additional capital depends on evolving regulatory requirements (FY27 and beyond)
- New nameplates: 2 SUVs (FY27)
- ICE launch: 1 mid-SUV (FY27)
- EV launch: 1 dedicated EV compact SUV (FY27)
- Export volume growth: 7%-8% (FY26-FY27)
- Capex: ₹7,500 crore (FY27)
- Real GDP growth: 6.2% (FY27)
- Nominal GDP growth: ~12% (FY27)
- Average crude price assumption: $95/bbl (FY27)
- Bank credit demand: to drive bulk of ratings growth (Near term / FY27)
- Bond market activity: to stay subdued near term (Near term / FY27)
- Revenue guidance: No formal revenue guidance (FY27)
- Tectonic revenue contribution: Meaningful FY27 revenues
- Outside top 20 growth: Growing faster than top 20 (FY27)
- EBITDA margin: Return to earlier higher levels in H2 FY27
- PAT trajectory: Significant upward movement (FY27)
- Formal revenue guidance: Not provided (FY27)
- Industry growth outlook: 5% to 8% CAGR (2026-2028)
- Tectonic revenues: Meaningful FY27 revenues
- $10m outcome-based deal: Entirely recognized in FY27
- EBITDA margin: Return to earlier levels in H2 FY27
- Toll business growth: 20% (FY27)
- Gross toll revenue: five-digit gross revenue number (FY27)
- Base toll growth assumption: around 10% (FY27)
- Tariff revision benefit: higher tariff growth from elevated December WPI (Apr 2027 reset)
- Profit growth: 25% CAGR (FY27 onward)
Jasch Industries (JASCH) reported strong standalone financial results for Q4 FY26, marked by significant top-line expansion and triple-digit growth in profitability metrics. Operating Leverage: The company's profitability growth significantly outpaced revenue growth, with EBITDA rising 135.4% and PAT rising 149.2% against a 56.6% increase in revenue.
- Book Growth (Loan Portfolio): 10–12% (FY27)
- Disbursement Growth: Double-digit (FY27)
- April FY27 Disbursement Growth (YoY): 20–21% (April FY27)
- Net Interest Margin: 2.5–2.7% (FY27)
- Spread: 1.94% (maintain similar level) (FY27)
- Revenue growth: double-digit growth (next year)
- EBITDA margin: no numeric range disclosed; visibility expected by next quarter (Q4 FY26)
- Pricing pass-through: majority of duty already passed through; further pricing to track duty and input costs (next 6 months)
- Middle East revenue growth: 20% annual growth from a 50,000-ton base (next year)
- RTH/RTC capacity: 15 million pouches added (next financial year)
- Overall gas volume growth: >10% (FY27)
- CNG volume growth: Normal growth rate (FY27)
- Pipe gas contribution to growth: Primary driver of FY27 delta
- EBITDA per scm: >Rs 8 (FY27)
- CNG price action: Further hikes if volatility persists (Near term)
- SUV volume growth: mid to high teens (FY27)
- Tractor volume growth: around 5% (FY27)
- LCV volume growth (<3.5T): high single digit (FY27)
- EV penetration on new platform: 13 to 21 over the five-year block (FY27-FY31)
- Incremental revenue from AI: Rs 4,100 Cr (FY27)
- Revenue growth: 10-12% minimum (FY27)
- Domestic vs export mix: Domestic revenue to outpace exports (FY27)
- EBITDA margin: Return to pre-investment profile (FY27 and beyond)
- Capex: Rs 10-15 Cr (FY27)
- New machinery: Additional machines at Sanand, Kolkata and Chandipur (FY27)
- Revenue growth: double-digit (FY27)
- Acute therapy growth: in line with IPM growth (FY27)
- Adjusted EBITDA margin: 25.5%-26.5% (FY27)
- Employee cost: around 22% of sales (medium term)
- OTC revenue growth: double-digit (FY27)
- Revenue from operations: Rs 12,500 Cr (FY26)
- Revenue growth: ~5% (FY27 vs FY26)
- PBT margin: 12-15% (normalized / future projects)
- Average margin: ~15% (ongoing shipbuilding portfolio)
- Order book: in excess of Rs 1 lakh Cr (FY27)
- Combined operating ratio / IFRS CISR: ~99% (FY29)
- Loss ratio: stable to +150 bps (FY29)
- ROE: mid to high teens; close to 11% currently (FY29)
- Retail health industry CAGR: 17-19% (5-year view)
- Expense of management framework: single limit of expense of management; possible glide path lower (future regulatory framework)
- Revenue recognition from signed orders: May not be visible in the next 1-2 quarters; implementation cycle can push revenue into later quarters. (Next 1-2 quarters)
- Japanese bank wins: Active discussions with top Japanese banks may produce results in the upcoming quarter. (Upcoming quarter)
- New market expansion: Vietnam and other geographies are being cultivated for growth optionality. (FY27 and beyond)
- Platform migration efficiency: AI-enabled transformation tooling should make legacy-to-Neo onboarding more seamless. (Ongoing)
- Net new money on opening NPI: 25-30%+ (FY27 / ongoing)
- Live ECM/advisory mandates: 40-45 (Near term)
- Investment banking year outlook: Good year expected (FY27)
- ARR revenue share: 60-65% (Medium term)
- Lending revenue share: 20-25% (Next few years)
- Indian tire industry growth: 7-8% (FY26)
- Capacity utilization: 70% (Q3 FY26)
- Capacity utilization increase: some increase (FY27)
- Sulfur price increase impact: 20-22 rupees (potentially up to 25 rupees) (current)
- Revenue ceiling at current realizations: Rs 1,200-1,250 Cr (near term)
- Mahad incremental revenue at current capacities: Rs 50 Cr (current capacities)
- Mahad incremental revenue at optimum utilization: Rs 60-65 Cr (optimum utilization)
- EBITDA margin: around 10% (FY27)
- Mahad utilization: 75-80% (next 1 year)
- Revenue growth: Above market growth; no formal numeric guidance (FY27)
- P3L turnover: 2x vs acquisition base (3 years)
- P3L EBITDA margin: Around 10% after forward investment (next 2 years)
- Earnings: Some softening near term (next 1-2 quarters)
- Capex: Rs 680-700 Cr (FY27)
- Standalone revenue growth: 20% (FY27)
- EBITDA margin: similar to current levels (FY27)
- EBITDA margin: 20%+ (going forward)
- Gross margin: similar level (next quarters)
- Installed capacity: 54,000 MT (by 30 Jun 2026)
- Revenue from operations: Rs 4,500 Cr (FY27)
- EBITDA margin: 7-8% (FY27-FY28)
- Group-side order inflow: Rs 5,000-6,000 Cr (FY27)
- External order inflow: Rs 1,000-2,000 Cr (FY27)
- Net debt / leverage: Debt free (By year-end or within 2 quarters)
- Transitionary phase duration: max next 2 quarters (near term)
- Broader normalization window: next 3-4 quarters
- Enterprise revenue share: 80-90% of top line (next 2-3 years)
- Consumer segment positioning: continue leadership position in consumer business (ongoing)
- AI integration: continue integrating AI across products and internal functions (coming quarters)
- Revenue growth: Around 20% (FY27)
- Project revenue conversion: Rs 3,000-3,500 Cr (FY27)
- Planned capex: Rs 300 Cr (Next year)
- Data center capacity: 5 MW ready by May next year (By May next year)
- Project business margin: 4-5% (FY27)
- Standalone AUM growth: 15-20% (FY27)
- Standalone AUM: 14,800-15,100 Cr (FY27)
- Standalone credit cost: 3-3.5% (FY27)
- Consolidated AUM growth: 25-30% (FY27)
- Consolidated AUM target: 32,000 Cr (2030)
- Order book: Rs 650 crore (next 3 years)
- Year-1 billing share: 50-60% of contract value (project year 1)
- Residual billing share: 8-10% over the remaining 4-5 years (project years 2-5)
- Addressable market: 25,000 plants (medium term)
- Annual recurring revenue per plant: Rs 1-5 crore (next 3 years)
- Quick-commerce business size: Rs 1 lakh crore (3.5-5 years)
- Quick-commerce CAGR: 35-50% (3.5-5 years)
- Quick-commerce contribution margin breakeven: current quarter (Q4 FY26)
- Growth after breakeven: unlock higher growth once the CM-positive headwind disappears (post-Q4 FY26)
- Food delivery growth: 18-20% (medium term)
- India realizations: +Rs 6,000/t vs Q4 FY26 (Q1 FY27)
- UK realizations: +£80/t vs Q4 FY26 (Q1 FY27)
- Netherlands realizations: +€80/t vs Q4 FY26 (Q1 FY27)
- India coal cost: +$15/t vs Q4 FY26 (Q1 FY27)
- Netherlands coal cost: +$10/t vs Q4 FY26 (Q1 FY27)
- Order pipeline: reasonably robust across domestic and international markets (near term)
- Q2-Q3 demand: possible impact if the war prolongs further (Q2-Q3 FY27)
- Supercritical order execution: 40-45 months (project life)
- Supercritical year-1 activity: design, engineering and ordering (FY27)
- Large-job execution cycle: 16-18 months (near term portfolio)
- Organic India revenue growth: mid-teens (FY27)
- Base business growth: higher than the previous year (FY27)
- Cost synergies: up to Rs 450 Cr (by year 3)
- Year 1 synergy capture: about 20% (year 1)
- Cumulative synergy capture: 60-80% (year 2)
- Top-line growth: 15% range plus/minus a few percentage points (next fiscal)
- Seaways bit margin: 30%-40% (FY27)
- Supply chain EBITDA margin: 9.5%-10.5% (next fiscal)
- Freight margin: flat to slightly lower for 1-2 quarters, then recovery (next 2 quarters)
- Capex: Rs 350-375 Cr (FY26)
- Company earnings trajectory: better next year for most textile companies including Vardhman (FY27)
- First-quarter trading environment: far better than Q4 conditions (Q1 FY27)
- Export order visibility: 2-3 months forward cover (current)
- Current yarn spread: about 95 cents (as of now)
- Average FY26 spread: about 65 cents (FY26)
- EBITDA: $450m (FY28)
- Phase 2 commissioning: this quarter (Q4 FY26)
- Cash generation: self-generating cash after this year (post-FY26)
- Alumina cost: ~$750 (Q2 FY27)
- Athena Unit 1 recommencement: no timeline committed (near term)
- Same Store Sales Growth: towards mid-single digits as early as possible (near term)
- Revenue: cross Rs 3,000 crore as early as possible (next year / near term)
- Gross Margin: 67%+ (near term)
- Annual price pass-through: 2-4% (FY27 and beyond)
- Operating EBITDA margin: 18-20% by December 2027 (Dec 2027)
- Revenue growth: 18% CAGR across the next 3 years
- Revenue milestone: cross Rs 1,000 Cr benchmark (FY27, if conditions improve)
- EBITDA margin expansion: about 200 bps (medium term)
- EBITDA margin improvement: 2-2.5% (next few years)
- Capex plan: Rs 100 Cr (next 24 months / FY30 completion window)
- AUM growth: 20% YoY (FY27 / medium term)
- PAT growth: 20% YoY (FY27 / medium term)
- Disbursement growth: 17-18% YoY (FY27 / medium term)
- Cost-to-income ratio: another 50 bps improvement (next financial year)
- Branch productivity: small branches profitable in 9-12 months; larger urban branches in 12-15 months (ongoing)
- EBITDA Margin: 13.5-14% (FY27)
- Volume Growth: 10-15% (Ongoing)
- Utilization: 55-60% (June quarter (Q1 FY27))
- Utilization: upwards of 70% (within a year)
- Formulation Revenue: at least thousands of crores (next 3-5 years)
- Order Growth: 25% (Q1 2026)
- Order Backlog: 11,000 Cr (Current)
- Revenue Growth: 6% (Q1 2026)
- Profitability: Muted growth (Q1 2026)
- Investment: $75 million (2026)
- NBFC ROA: 2.5% by end FY27
- NBFC Net Interest Margin: 25-30 bps expansion from improved product mix (FY27)
- NBFC credit cost: 1.1-1.2% range (FY27)
- Housing Finance NII: Rs 5.10-5.13 Cr range (FY27)
- Housing Finance OPEX-to-AUM: 2.10% (from 2.4% in FY26) (FY27)
- Annual Store Additions: 25+ stores per year (FY27–FY28)
- Same-Store Sales Growth: Double-digit trajectory (Medium-term)
- FY27 Summer Demand: Strong; above-normal heatwave days forecast by IMD (FY27 Q1)
- EBITDA Margin: 8–10% range (Medium-term)
- Gross Margin: Stable at 15–16% range (Medium-term)
- CRAMS + CEM revenue mix: 70%+ by FY30 (from current 55%)
- LSM pricing environment: Elevated prices to persist for next 2–3 quarters (Q1–Q3 FY27)
- Site 5 Phase 1 contribution: Meaningful revenue contribution from May–June 2026 onwards (FY27)
- EBITDA margin: 29–30% in FY27
- PAT margin: 19–20% in FY27
- AUM Growth: 22–24% (FY27)
- Disbursement Growth: Implied ~5,000–5,100 Cr annual disbursements (from 4,009 Cr in FY26) (FY27)
- ROE: 20%+ (FY27 onwards)
- ROA: Implied to remain in 7.9–8.2% range (FY27)
- Net Interest Margin (Spread): Incremental impact from rate reduction ~10–15 bps on disbursement yield; offset by productivity and potential opex leverage (FY27)
- Bajaj Life NBM: Positive trajectory; GST mitigation benefits to flow through FY27
- Bajaj General combined ratio: On-basis combined ratio at healthy 101.9%; expected to stabilize as timing variances normalize (FY27)
- Bajaj Finance AUM growth: Continued momentum; new loan bookings up 21% YoY (FY27)
- Bajaj Finance GNPA/NNPA: Asset quality stable; stage 2 and stage 3 assets decreased 430 Cr in Q4 (FY27)
- Bajaj Housing Finance AUM growth: 23% growth; diversified across home loans, LAP, LRD, developer finance (FY27)
- FY27 revenue: Rs 1,450-1,500 Cr (FY27)
- Garment revenue growth: 20% (FY27)
- Fabric revenue growth: 20% (FY27)
- Long-term revenue capacity: Rs 2,000 Cr+ without significant capex (long term)
- EBITDA margin: 10.5%-11% over the medium term
- EBITDA Margin: Maintain annual margin levels (Annual)
- PBIT/PBT Margins: 7-8% (Medium to long term)
- Volume Growth: No specific percentage guidance (FY27)
- Ground Share: Target 48-50% (Future)
- Organic revenue growth: 15-16% (FY27)
- STEAG annualized revenue: Rs 700 Cr (post-close / FY27)
- LSG annualized revenue: Rs 110 Cr (post-close / FY27)
- High-margin telecom & industrial share: 33% of revenues (post-acquisition)
- EBITDA margin: Touching distance of 5% on a sustained basis (near future / FY27)
- Plywood capacity expansion: About 30% (FY27)
- Plywood capacity expansion: Another 15% (FY28)
- Hoshiarpur plant commissioning: October this year (FY27)
- New plant readiness after land acquisition: 15-16 months (FY28-FY29)
- Brownfield MDF capacity addition: 60-70,000 CBM (Q1 FY27)
- RE Power Sales Capacity Addition: Minimum 1,500 MW (1.5 GW) (FY27)
- Reported EBITDA to Run Rate EBITDA Ratio: 1.1 times (Historically)
- Revenue Stabilization Period: 3 to 6 months (Post-commissioning)
- Organic revenue growth (India business): 15%+ (FY27)
- Inorganic revenue growth (acquired brands): 25% (FY27)
- International business CAGR: 8-9% (high-single-digit) (next 3-4 years)
- Vocadin revenue growth: 25% CAGR (3-4 years)
- Gross margin: 80%+ (FY27 onwards)
- Operational impact from cane development: Major impact visible from FY2027 (FY27)
- Sugarcane juice/syrup/B-heavy molasses usage: Use permitted for ethanol production to optimise product mix and market-linked output (Season 2024-25 onward)
- Maize utilisation: Use maize in the multi-feed plant to maximise capacity utilisation (Season 2024-25 onward)
- Distillery capacity: 350 KLPD commissioning after pending approvals (Near term)
- Buyback consideration: Up to Rs20 crore (FY25/FY26)
- Mobile volumes ex-Vivo: about 32 mn units (FY27)
- Vivo annualized volumes: 20-22 mn units (annualized)
- Incremental PLI2 volume upside: 4-5 mn units (FY27)
- Export-led feature phone/smartphone volumes: start from mid-Q2 (FY27)
- Company revenue: about Rs 56,000 Cr without Vivo (FY27)
- Credit cost: 2% steady state (FY28)
- Loan growth: 20-25% steady state
- Net Interest Margin: 7% +/-0.5% (steady state)
- ROA: 2% (FY28)
- Cost/income ratio: 65% +/-2% (steady state)
- Gas marketing segment PBT: Minimum ₹4,000 Cr if the West Asia crisis persists for the full FY27
- Gas marketing segment PBT: Minimum ₹4,500 Cr if the geopolitical situation normalizes by mid-Q2 FY27
- Natural gas transmission volume: Around 119 MMSCMD if the West Asia crisis starts normalizing by mid-July 2026 (FY27)
- Natural gas transmission volume: Around 115 MMSCMD if the West Asia crisis persists through the full FY27
- Capex: Approximately ₹11,500 Cr (FY27)
- Consolidated revenue: Rs 17,000-18,000 crore (FY27)
- Europe growth: high single digit (FY27)
- India business growth: 15%+ (FY27)
- EBITDA margin: 21-22% (FY27)
- US respiratory launches: 2 sole FTFs in end-Q3 and Q4; 2-3 additional launches in FY27
- Consolidated PAT margin: 40-45% (FY26 / Q4 FY26)
- Q4 FY26 consolidated PAT margin: ~45% (Q4 FY26)
- IPO approvals pending: 3-4 approvals by month-end (This month)
- Listings to close: All remaining companies within the quarter (Q4 FY26)
- Quarterly revenue cadence: Q2/Q4 stronger; Q1/Q3 weaker (Ongoing)
- Gross refining margins: Remain on the higher side (next 1-2 years)
- Marketing margins: Remain intact (near term)
- FY27 capex: Rs 32,700 Cr (FY27)
- Standalone refining throughput: ~75 MMT (FY27)
- CPCI refining throughput contribution: ~10 MMT (FY27)
- Dombivli phase 1 beds: 200 beds at launch (Feb 15 / phase 1)
- Bibvewadi phase 1 beds: 200-220 beds (FY28)
- Mira-Bhayandar capacity: 300 beds, operational by 2028
- Dombivli EBITDA drag: 2-3 Cr per month in the first year (Year 1)
- Dombivli break-even: by end of year 2 (By year 2)
- Volume growth: Double-digit growth from here (From Q4 FY26 onward)
- EBITDA margin: 17-18% (FY26 and next year)
- Capex: No major capex (Next 1-2 years)
- Capacity expansion mode: Replacement lines and outsourcing instead of a large greenfield cycle (Next 1-2 years)
- Cash balance: Likely to increase (Next 1-2 years)
- Consolidated revenue growth: Double-digit growth (15-20% implied) (FY27)
- Domestic revenue growth: Double-digit growth expected as Jaljeevan Mission funding normalizes (FY27)
- International revenue growth: Continued growth with SPP UK stabilization and US data center ramp (FY27)
- Consolidated EBITDA margin: Recovery to 15%+ levels (from 13.7% in FY26) as labour code costs are non-recurring (FY27)
- SPP UK EBITDA margin: Recovery to FY25 levels by Q3 FY27 as service business mix improves
- Company volume growth: about 10% (FY27)
- Additional annual volume from new plants: 250,000 cars (FY27)
- Production capacity: 4 million units per annum (medium term)
- EBIT margin: healthy trajectory once war, commodity and energy headwinds subside; no explicit numeric target (FY27 onward)
- Charging points network: over 1 lakh charging points (by 2030)
- Consolidated EBITDA margin: 20% now; normalizes to slightly over 22% (FY26 / steady state)
- UK steady-state EBITDA margin: around 22% (medium term)
- Quarterly insurance losses: another quarter or 2 in the current range; significant decline over the next 3 quarters
- Account price increase: 30%-35% of accounts repriced in June (June / next quarter)
- Total project capex: INR 3,000 crore (through FY28/FY29)
- Alumina production: 25 lakh tons (FY27)
- Alumina sales: 25 lakh tons (FY27)
- Metal production: 4.73 lakh tons (FY27)
- Domestic alumina sales: 2.5-3 lakh tons (FY27)
- 5th stream incremental output: 2 lakh tons minimum; upside to 3-3.5 lakh tons (FY27 ramp)
- Revenue CAGR: about 35% (next few years)
- New stores: at least 20 (FY27)
- Topline run-rate: about Rs 190 Cr (FY27)
- Topline run-rate: about Rs 260 Cr (FY28)
- Operating margin: around 42.92% with potential upside of 100-150 bps (FY27-FY28)
- Revenue growth: 15-20% YoY (FY27 / near term)
- New products growth: 25% over last year (next year)
- New business from new products: Rs 150-200 Cr (next 2 years)
- EBITDA margin: 12% to 15% (next 2-3 years)
- Gross margin improvement: 100 bps each year (next 2-3 years)
- Total income growth: double-digit growth (FY27)
- Branded apparel growth: double-digit growth (FY27)
- Garmenting outlook: next year should be much better than this year (FY27)
- Bottom-line growth: double-digit growth, faster than top line (FY27)
- Core apparel EBITDA margin: double digit (next 2 years)
- Overall consolidated revenue growth: same growth level as FY26 (FY27)
- Crane rental growth: 30% (FY27)
- Consolidated top-line growth: in the range of FY26 growth (FY27)
- Deferred India capex: Rs 123 Cr (FY27)
- Additional India capex: Rs 190 Cr (FY27)
- Revenue growth: At least 25% (FY27)
- Revenue growth: Above 40% if UAE improves (FY27)
- Total revenue: 500+ Cr (FY27)
- India revenue: Around 200 Cr (FY27)
- Revenue mix: 60:40 this year, 50:50 thereafter (FY27 and beyond)
- Overall business growth: 27-30% annual growth (FY27)
- Hyperlocal growth: 45-50% YoY (FY27)
- Growth mix: 50-55% from market growth and 40-45% from share gains (FY27)
- Digital penetration: 14-15% (FY30)
- Annual digital penetration increase: 120-150 bps (each year)
- Industry cement demand growth: 7.1-7.2% (FY27)
- Company cement demand growth: 8-8.5% (FY27)
- Company volume growth versus industry: 1% above average industry growth rate (FY27)
- Cement volume: about 40 million tons (FY27)
- FY27 capex: Rs 1,500 Cr (FY27)
- FY27 capacity additions: Buxar 660 MW, Dholasidh 69.5 MW and ~555 MW solar (FY27)
- FY28 capacity additions: ~650 MW solar (FY28)
- FY29-FY30 capacity additions: another ~2,500 MW (FY29-FY30)
- Capex: Rs 9,400 Cr (FY27)
- Capex: Rs 7,800 Cr (FY28)
- US revenue: 375-400m (FY28)
- Growth timing: H2 FY27 onward (FY27-H2 onward)
- EBITDA margin: upwards of 20% (long term)
- Gross margin: 58-60% (long term)
- Capex: around Rs 300Cr (next 2 years)
- Consolidated top-line growth: High single digit (FY27)
- R&D spend as % of sales: 6%-7% (FY27)
- Effective tax rate: Around 25% (FY27)
- Organon acquisition closing: Expected in Q4 FY27
- Lexelvi / Unloxit sales outside the US: No sales factored in for FY27
- Consolidated adjusted EBITDA breakeven: by Q3 FY28
- Adjusted EBITDA: 1,000 Cr (FY31)
- India consumer services adjusted EBITDA margin: ~10% of NTV over a longer period (Long term)
- Native breakeven: next few quarters (Next few quarters)
- New international geographies: none beyond UAE, Singapore and KSA JV (Foreseeable future)
- FY27 revenue growth: double-digit YoY growth (FY27)
- ADR target: Rs 9,000-9,500 (near term)
- ADR long-term target: Rs 10,000 (long term)
- EBITDA margin: above 30% (near term)
- Long-term EBITDA margin: 40% (long term)
- Barjora line utilization: At least 50% (FY27)
- UAE trial production: By Aug/Sep 2026 (FY27)
- UAE commercial production: Later this year / shortly after trial production (FY27)
- India lines production status: Full production (Next year)
- UAE line utilization: In excess of 50% (Next year)
- Volume growth: 35-45% (FY27)
- Revenue: 1,500 Cr (FY28)
- EBITDA margin: 2-3% higher than FY26 (FY27)
- Gross margin: 40-42% (FY27)
- FY27 capex: 125 Cr (FY27)
- Volume Growth: 15-20% (FY27)
- EBITDA Growth: 20-25% (FY27)
- PAT Growth: 25-30% (FY27)
- EBITDA per ton: 5,000-5,500 rupees (Future)
- Total CAPEX for 8 million tons capacity: 1400-1500 crore (Next 2.5 years)
- HALS volume: over 1,000 tons (Q4 FY26)
- HALS utilization: 40% (March FY26)
- HALS blended realization per kg: 460 rupees (Q4 FY26)
- HALS blended realization per kg target: 7-7.5 dollar (future)
- Hydroquinone catechol plant optimization: 1-2 quarters (future)
- Revenue growth: double-digit growth (FY27)
- Capex: constant capex next year unless a major custom synthesis project or new project emerges (following year)
- Kakinada expansion: Rs 1,500 Cr expansion plan, with Rs 600 Cr already capitalized (ongoing)
- Dedicated CS commercialization: hopeful by 2027 or earlier or later, subject to customer approvals
- Revenue conversion cycle: 6 months to 3 years, with a comfortable 2-year range (project-dependent)
- FY27 revenue contribution from bromine and vacuum salt: Rs 120 Cr (FY27)
- Peak annual revenue contribution at full utilization: Rs 170 Cr (full utilization)
- EBITDA margin from bromine and vacuum salt: 40-45% (FY27 / full utilization)
- Commissioning timeline: start in May-June; full commissioning in Q1 FY27
- Construction start: after land acquisition and land conversion (current)
- Revenue growth: 27-30% (FY27)
- Long-term revenue growth: >20% (Long term)
- EBITDA margin: ~14% (FY27)
- Long-term EBITDA margin: >13% (Long term)
- Signaling EBITDA margin: ~20% (FY27)
- Revenue growth: 15-20% growth (current year / FY27)
- Long-term revenue target: Rs 3,000 Cr (Mar-31 FY31)
- EBITDA margin: 18-20% (FY27)
- Capex: Rs 135 Cr (FY27)
- Second block commissioning: Sep-Oct 2026 (FY27)
- Visible growth at start of FY27: 12-13% (Beginning of FY27)
- Organic revenue growth target: 18-20% (FY27)
- Typical visibility expansion during the year: 8-10% addition from starting visibility to year-end (FY27)
- Technology vertical growth: 5-8% (FY27)
- Consumer vertical growth: 18-22% (FY27)
- Standalone AUM growth: 15% in Q1 (Q1 FY27)
- Guidance review timing: Revisit after Q1 or Q2 (FY27)
- Muthoot Finance branch additions: 200-300 branches (FY27)
- Yield / pricing: Dynamic; no fixed yield commitment (FY27)
- Profit guidance: No formal guidance provided (FY27)
- Capex: Rs 500-700 Cr over the next 2 years, excluding SKS expansion (FY27-FY28)
- 600 MW thermal expansion: Full-blast capex starts next year after clearances (from next year)
- 50 MW solar plant: Commissioning before the end of the next quarter (Q1 FY27)
- 30 MW TG set replacement: Commissioning by end of this quarter (Q1 FY27)
- Small hydro projects: 3-4 years for the 3 small hydro projects and 3-4 years for Ghatam (next 3-4 years)
- Revenue growth: 15% (FY27)
- Revenue growth ambition: 20-25% (going forward)
- EBITDA margin: 22% (FY27)
- Capex programme: Rs 280 Cr (FY27)
- Capex completion: by FY27 March
- Top-line growth: 7-10% (next 3 quarters)
- FY27 revenue: Rs 2,700-2,800 Cr (FY27)
- Downstream acquisition contribution: ~Rs 200 Cr (FY27)
- Quarter-on-quarter margin expansion: 15-20% (next 2-3 quarters)
- Cotton yarn spread: >$1.00 (current run-rate / near term)
- EBITDA Margin: 20% (FY28)
- Total Capex: 300 Cr (FY27)
- SDC Capacity: 92,000 tons (Q3 FY27)
- Revenue run-rate: US$2 billion (FY27 Q4 exit)
- Quarterly exit run-rate: US$500 million (FY27 Q4)
- EBIT margin: 16-17% aspiration (FY27)
- AI adoption in technology: highest and fastest (FY27)
- AI adoption in healthcare and BFSI: slower than technology; still progressing (FY27)
- Experience Centre Expansion: ~400 new branches planned for FY27
- Branch Opening Pace: Accelerated branch opening in H1 to capitalize on near-term EV tailwind (H1 FY27)
- EL Trial Production: Trial production expected before end of calendar year (likely around festival season) (Calendar 2026 (H2 FY26/H1 FY27))
- EL Full Capacity: Full 42,000 units/month capacity operationalized post trial phase (FY27)
- EBITDA Margin Improvement: Continued margin expansion driven by better unit economics, disciplined cost management, and operating leverage (FY27 onwards)
- Revenue growth: double-digit growth (FY27)
- Validations and launches: 1-2 validations and 1 commercial launch (FY27)
- Customer forecast visibility: encouraging annual forecast from the customer (FY27)
- PI/API revenue trend: grow over the FY25 peak sale (FY27)
- Shipment normalization: orders are in hand and supplies are rolling out (FY27)
- Non-MF Revenue Growth: 20%+ (FY27)
- Payments Revenue Growth: 20+ Cr incremental (FY27)
- Alternatives Revenue Growth: 7–8 Cr incremental (FY27)
- KRA Revenue Growth: Flat (post NSE integration and account-opening headwinds) (FY27)
- EBITDA Margin: 46%+ (at least retain Q4 FY26 level) (FY27)
- New Sales Booking: 20,000 crores (Annually)
- New Margin Creation: 9,000-10,000 crores (Every year)
- Free Cash Flow: 7,000-8,000 crores (Every year)
- NOI Growth: Mid-teens (Next 4-5 years)
- Annuity Business Growth (CAGR): 20-25% (Next 4-5 years)
- Tractor industry growth: 2% to 3% up, or 2% to 3% down (FY27)
- H1 FY27 tractor demand: At par versus last year (H1 FY27)
- H2 FY27 tractor demand: Substantial degrowth versus last year (H2 FY27)
- Raw-material inflation: 5% to 6% cost increase (Near term)
- Price hike: About 1.5% already taken (April and recent months)
- EBITDA: Rs 225-250 Cr (FY27)
- Total volume: 180,000-200,000 MT (FY27)
- RPET volume: ~85,000 MT (FY27)
- Top-line CAGR: 20%+ (Long term)
- Installed capacity target: 97,000-100,000 TPA (By FY27 end)
- Company top-line growth: Double-digit growth remains the ambition (medium term)
- GenMed top-line growth: 6-8% underlying growth (FY27)
- Vaccine business growth: Strong high-double-digit growth (FY27)
- Innovation portfolio contribution to top line: 10% of top line (medium term)
- Belantamab launch timing: Within the next 6 months / this financial year (FY27)
- Raipur occupancy rate: 30% (FY27)
- Howrah occupancy rate: 60% (Q1 next year)
- Jamshedpur occupancy rate: 10-14% (first year)
- Raipur break-even: monthly break-even (FY27 ramp-up)
- ARPOB growth: around 8% (FY27)
- Core lubricants volume growth: Continued share gains; no numeric FY26 target disclosed
- Consumer activation: Continue IPL-led promotions, Gulf Fan Academy and ambassador-driven campaigns (FY26)
- eMobility investment: Continue building the Tirex, Indra Technologies and Electreefi ecosystem (FY26)
- Pre-sales: Rs 6,000 Cr (FY27)
- Collections: Rs 3,000 Cr (FY27)
- Total debt reduction: At least 35% reduction (by year-end)
- Use of surplus cash: Primarily for repayment of high-cost debt (FY27)
- 25 South delivery: This year (FY26)
- FY27 revenue growth: 18-20% (FY27)
- Quarterly revenue growth run-rate: similar fashion to FY27 annual target (FY27 quarters)
- Quarterly order inflow: Rs 450-500 Cr per quarter (FY27)
- Aerospace order flow: few more orders of similar nature and value very soon (Q1-Q2 FY27)
- EBITDA margin: 21-24% (FY27)
- EBITDA per tonne: Rs 19,000-21,000 (FY26)
- 9M FY26 average EBITDA per tonne: Rs 21,300 (9M FY26)
- Capex: Rs 2,700 Cr (FY26)
- Capex spent: Rs 2,200 Cr (9M FY26)
- Maintenance capex: Rs 500 Cr (annual)
- IPO pipeline size: Rs 200,000 Cr (by Oct)
- Capital markets execution: H2 stronger than H1 (H2 FY27)
- FPI window: 12-18 months (next 12-18 months)
- Recovery: Rs 250-300 Cr (FY27)
- Private-market loan book: Rs 5,000 Cr (March 2027)
- Pre-sales: 20-22% below initial guidance (FY26)
- Collections: ~10% below target (FY26)
- Revenue from operations: considerably higher than the first 3 quarters (Q4 FY26)
- Profitability: correspondingly higher than the first 3 quarters (Q4 FY26)
- Launches: ~9 million sq ft (FY27-FY28)
- Decorative revenue growth: marginally negative to flat (Q3 FY26 / near term)
- Industrial growth: touching double digits (near term)
- EBITDA margin: 13%-14% (near term)
- Gross margin: better, not significantly different (Q4 FY26)
- Pricing trend: very stable (near term)
- Revenue growth: 20%+ (FY26 full year)
- Q4 growth: >25% (Q4 FY26)
- Volume growth: 16%-18% (FY26)
- EBITDA margin: around 11% (FY27)
- Sanand turnover: Rs 2,700 Cr (next financial year)
- New-unit EBITDA losses: Less than half of FY26's 128 Cr drag (FY27-FY28)
- Telangana EBITDA growth: 10-12% (FY27)
- Thane EBITDA: EBITDA neutral (March-April 2026 exit)
- Bangalore / PES profitability: EBITDA positive by before October for one unit and by end-FY27 for PES
- New Kondapur capacity: 800 beds (June FY27)
- Volume growth: Double-digit growth in volumes (coming years)
- Q4 FY26 volume base: Q4 FY26 volumes can now become a base (near term)
- New products contribution: Pickup mode in FY27; meaningful impact toward end of the year
- EBITDA improvement: Another 150 bps improvement from FY26 base (forward)
- Price pass-through: Price hike impact should play out in the upcoming quarter (next quarter)
- Payments and lending GMV growth: 30-35% (FY27)
- Digital credit GMV growth: 30-35% (FY27)
- Payments revenue growth: to follow GMV growth over the next few quarters
- EBITDA margin: similar to the 5% range (FY27)
- Payments net margin: 12-15 bps (mid-to-long term)
- Net new restaurants (India): 60-80 openings per year (annual)
- India restaurant count: around 800 by FY29
- Gross margin: 70.0% FY29 target effectively achieved at 70.2% in Q4 FY26
- Free cash flow neutrality: 6-8 quarters (next 6-8 quarters)
- Free cash flow positive: FY28 broadly positive
- Consolidated revenue: Rs 5,600-5,700 Cr (FY27)
- Silvassa revenue: Rs 3,100 Cr (FY27)
- Punjab revenue: Rs 2,600 Cr (FY27)
- Peak revenue after Phase II and cotton expansion: Rs 7,500-7,600 Cr (by FY28 end)
- Consolidated EBITDA: north of Rs 500 Cr (FY27)
- Revenue growth: 20%+ (FY27)
- Signed revenue visibility: 48% of FY26 revenue already aligned in the engine (Start of FY27)
- EBITDA margin: 25-27% (FY27)
- Internal EBITDA margin target: Closer to 30% (FY27-FY28)
- Cost reduction potential: 7-8% reduction on current cost base (FY27)
- Pre-sales: INR1,800-2,000 Cr (FY27)
- Revenue growth: 55-60% (FY27)
- PAT growth: 55-60% (FY27)
- H1 FY27 launches: 3 projects (H1 FY27)
- Combined revenue potential: INR2,500-3,000 Cr (H1 FY27)
- Revenue growth: upwards of 15% (this year)
- IKEA initial revenue: Rs 40-50 Cr (this year)
- IKEA full-capacity revenue: Rs 200-250 Cr (full utilization)
- Export growth: little higher than company growth rate (this year)
- EBITDA margin: protect 11% and improve from there (FY27 / medium term)
- Top-line target: 2x top line by 2030 (Vision 2030)
- Private-sector wagon share: 40-45% (current run-rate / medium term)
- Private-sector wagon market size: 12,000-15,000 wagons (consistent basis)
- Board-approved defense capex: Rs 200 Cr (current approval)
- Overall defense investment bucket: Rs 1,500-2,000 Cr (as of now)
- Earnings outlook: No forecast provided (Near term)
- Scenario analysis for Hormuz reopening: Not quantified; direction depends on cargo rerouting and ship repositioning (Near term)
- Time charter activity: Below 20% (Ongoing)
- Vessel days already locked in: About 80% (This year)
- Rig repricings: 3 rigs (This financial year)
- Q1 operating environment: Good healthy Q1; no headwinds visible (Q1 FY27)
- Corporate travel volumes: No reduction currently (Q1 FY27)
- Occupancy: 65-70% (FY27)
- Middle East recovery: 50-60% recovery (By year-end FY27)
- Demerger completion timeline: 12-15 months (FY27-FY28)
- FY26 capex - distribution: Rs 1,600 Cr (FY26)
- FY26 capex - transmission: Rs 550 Cr (FY26)
- FY26 capex - thermal: Rs 700 Cr (FY26)
- FY26 capex - renewables: Rs 6,500 Cr (FY26)
- Total capex plan: Rs 80,000 Cr (next 5 years)
- Revenue growth: 4-8% (FY26)
- EBITDA growth: 12-16% (FY26)
- Regional revenue growth: Growth in every region (Q4 FY26)
- Q3 sales deferred into Q4: About $30m (Q4 FY26)
- New product launch revenue: Exceed $130m (FY26)
- Pre-sales: Rs 2,200 Cr (FY27)
- Launch pipeline GDV: Rs 6,324 Cr (FY27)
- Total revenue visibility: Rs 10,432 Cr (Medium term)
- Wadala land bank GDV: Rs 13,194 Cr (Medium term)
- Selective project additions: Rs 1,800 Cr (FY27)
- Consolidated Revenue Growth: Low double-digit range (FY27)
- US Business Revenue Growth: 10-15% (FY27)
- Ex-US Markets Revenue Growth: 15%+ (FY27)
- API Business Revenue Growth: High-single or low-double-digit (FY27)
- India Business Growth: Closer to market growth (FY27)
- Volume growth: 5-10% (FY27)
- Finished-goods pricing: 30-40% higher than February levels (Near term)
- Margin direction: Better than the first 11 months of FY26 (FY27)
- Pre-February pricing: Unlikely to return soon (Near term)
- Capex: Rs80-90 Cr (FY27)
- Overall revenue growth: mid-teens (FY27)
- Export revenue growth: 20% (FY27)
- EBITDA margin: around 13.1% (FY27)
- Capex: around Rs 400 Cr (FY27)
- Maintenance capex: Rs 40-50 Cr (FY27)
- FY27 Revenue Growth: 24–27% (FY27)
- FY29 Revenue Target: Rs 3,200 Cr (FY29)
- Order Book Execution Cycle: 12–14 months (Rs 2,196 Cr); 15–36 months (Rs 1,245 Cr long-term contracts) (FY27–FY28)
- EBITDA Margin: Expansion expected from 10.8% (FY26) as operating leverage plays out (FY27–FY29)
- Gross Margin: 33–35% range maintained; underlying performance better than reported due to tariff pass-through (FY27 onwards)
- Coatings divestiture closing: Expected in Q2 2026, subject to customary approvals
- Agricultural Solutions legal/ERP separation: Targeted for 2027 (FY27 / 2027)
- Minority IPO readiness: Potential mid-term option (mid term)
- U.S. tariff impact: Too early to quantify; direct sales to the U.S. are nil (near term)
- Margin pressure: Pressure from pricing and higher energy costs persists (near term)
- ARPU growth: continue to grow for many quarters to come (next several quarters)
- Pricing architecture: move away from flat unlimited plans toward tiered allowance structures (medium term)
- Group capex: in the ballpark of this year, give or take a little bit (FY27)
- Edge data centers: 56 world-class edge data centers (next 18-24 months)
- Core radio capex: moderating in India (FY27)
- Production volume: 122,000-130,000 MT (FY27)
- Installed capacity: 175,000-190,000 MT (next 12-15 months)
- Installed capacity: 350,000 MT (FY29)
- Revenue: INR3,500 Cr at INR100,000 per tonne (FY29)
- LOI / CoC closure: June (near term)
- Focused IT monthly derivatives launch: 11 May 2026 (FY27 start)
- Monthly index derivatives: 3 products approved (Focused IT, Focused Mid cap, Sensex Next 30) (FY27)
- Longer-tenor contracts: Expanded participation in longer-tenor contracts (FY27)
- Broker count: 700 brokers (Near term)
- FPI / institutional participant count: 800 participants (Near term)
- Revenue from operations: ₹1,000-1,050 Cr (FY27)
- Organic platform margin growth: 2%-3% more margin growth (next few quarters)
- Consolidated percentage margin growth: 1%-1.5% (next 12 months)
- Steady-state EBITDA margin: 25%-30% (steady state)
- Organic NRR: 115% (ongoing planning assumption)
- Operating EBITDA margin: 21-24% (medium to long term)
- Standalone performance: Better than Q4 FY26 (Q1 FY27)
- Consolidated performance: Better than Q4 FY26 (Q1 FY27)
- Phenolics profitability: Healthy and improving versus Q4 FY26 (Q1 FY27)
- New products: Regularized commercial production from Q3 (Q3 FY27)
- MIBK/MIBC commissioning: Tail-end Q1 or early Q2 (Q1-Q2 FY27)
- Summer brand growth: double-digit growth (H1 FY27)
- Navratna growth: double-digit growth (H1 FY27)
- Dermicool growth: double-digit growth (H1 FY27)
- International growth: close to single-digit growth (Q1 FY27)
- International growth: double-digit growth (Q2 FY27)
- Revenue growth trajectory: same growth zone as the last few quarters (FY27)
- Profitability trend: continued improvement, with some beauty retail efficiency reinvested into growth (FY27)
- Store additions: 50-70 stores in FY27
- Store network target: 500 stores over the next 3-4 years
- Nykaa Now marketing: market more aggressively (FY27)
- Volume growth: 7-8% (FY27)
- Long-term growth: double-digit growth (longer term)
- EBITDA margin: broadly FY26 equivalent levels (FY27)
- Advertising & promotion expense: 1.6-2.0% of revenue (coming year)
- Additional capex: Rs 15-20 Cr (coming year)
- Residential booking value: Above Rs 39,000 Cr (FY27)
- Collections: Above Rs 24,000 Cr (FY27)
- Return on equity target: 20% (FY28)
- Free cash flow: Could be positive, but may be break-even depending on BD (FY27)
- Free cash flow: Strongly positive (FY28)
- Revenue growth: continued strong double-digit growth across businesses (FY27)
- International business contribution: international business remains a growth driver (FY27)
- Margin expansion: continued improvement through disciplined execution and solutions-led mix (FY27)
- Aftermarket contribution: aftermarket remains an important support to margins (FY27)
- Excel Controlinkage remaining stake: 20% to be acquired in Q2
- Finished goods volume growth: late-teen growth (FY27)
- Commercial vehicle revenue growth: 35-40% growth (FY27)
- Farm equipment market share: improvement of almost 4% (FY27)
- EBITDA margin: broadly in line with FY26 levels (FY27)
- Gross margin: improvement from current level (FY27)
- Revenue guidance: No specific guidance on revenue or earnings projections (near term)
- New OTTplay subscriptions: No new OTTplay subscriptions from 1 Apr (from 1 Apr FY27)
- Residual OTTplay P&L impact: Very small FY27 loss from servicing legacy subscriptions
- Closure losses: No further closure losses expected from discontinued businesses (FY27)
- Statutory items: Labour-code changes may still impact financials (ongoing)
- Q1 FY27 ferrochrome sales volume: ~80,000 tons (Q1 FY27)
- FY27 output: ~400,000 tons (FY27)
- FY28 output: 475,000-500,000 tons (FY28)
- Q1 FY27 realization / margin trend: Higher than Q4 FY26 (Q1 FY27)
- Q2 FY27 price trend: Around the same as Q1 FY27 (Q2 FY27)
- Presales: Rs 5,000 Cr (FY27)
- Project launches GDV: Rs 8,000 Cr (FY27)
- Acquisitions / BD additions GDV: Rs 8,000+ Cr (FY27)
- Gross debt-to-equity ratio: capped at 0.75:1 (FY27)
- Revenue mix: 60% POCM / 40% residual completion method (FY27)
- Consolidated revenue growth: Above 20% (FY26-27)
- Margin appreciation: Expected to improve (FY26-27)
- Waste management qualification: 800-1000 tpd (Next 18 months)
- Citlum India acquisition: 100% acquisition approved (Near term)
- Non-nuclear revenue growth: minimum double-digit; better than double-digit seen as sustainable (FY26-FY27)
- Export growth: robust growth, faster if tariffs normalize and geopolitics stay supportive (FY26-FY27)
- Solar business growth: about 50% growth from last year (FY26)
- Solar order book: more than ₹250 crore (current order book)
- GHAPV deliveries: 4 pumps by March 2026 and the remaining 4 in 2027 (FY26-FY27)
- India volume growth: high single digit (FY27)
- International constant currency growth: mid teen (FY27)
- Consolidated revenue growth: double digit growth across >Rs 15,000 Cr revenue (FY27)
- Consolidated revenue: >Rs 20,000 Cr (FY30)
- EBITDA growth: high teen (FY27)
- Sales / volume momentum: Continuation in the current quarter as new launches and replacement models support volumes (Current quarter / Q1 FY27)
- OEM launch timing: No fixed date; volumes depend on customer launch schedules and regional model rollouts (FY27)
- Gross margin: Should return toward normal mature levels if copper stays near the current base (Next few quarters)
- EBITDA margin: Some denominator effect remains, but the lagged cost recovery should narrow the Q4 squeeze (Next few quarters)
- Startup cost normalization: Normalization of greenfield startup costs should take a few quarters (Few quarters)
- FY27 operating momentum: strong year (FY27)
- Quarterly revenue cadence: not every quarter will be a big jump; cyclicity remains (FY27)
- Expense discipline: spend smart on technology, people and market development (FY27)
- Margin focus: efficiency over absolute cost reduction (FY27)
- Product pipeline: next lot of products prepared across energy, metals and indices (FY27)
- Generation slowdown: No slowdown expected (FY27)
- Teesta-5 generation restart: June 26 (FY27)
- Subansiri Lower generation: 5,000-5,500 MU (once all 8 units are commissioned / FY27 run-rate)
- Parbati-II final tariff order: By 30 July 26 / end of this quarter (Q1 FY27)
- Subansiri Lower interim tariff order: First interim order first; final order within ~6 months (next 6 months)
- Revenue growth: Double-digit growth (Near term)
- GCC growth: Double-digit growth (Next few quarters)
- North America / US business: Normalization after tariff-related inventory flush (Near term)
- Price increases: Another calibrated round (Q1 FY27)
- EBITDA margin: Protected through pricing, mix and cost control (FY27)
- Consolidated revenue growth: 20-30% (FY27)
- Alloy division growth: 3-4x FY26 (FY27)
- Relay revenue: Rs 10-15 Cr in Q4 FY27
- EBITDA margin: 15-18% (FY27)
- PML capex: Rs 40-50 Cr (FY27-FY28)
- Underlying volume growth: about 100 bps expansion going forward (FY27 / going forward)
- Q1 demand momentum: perhaps yes (Q1 FY27)
- EBITDA margin corridor: 24-25% corridor (FY27)
- Fevicol price increase: about 12-15% (April-May 2026)
- Capex intensity: 3-5% of revenue turnover (Ongoing)
- Total Loan Book: > 1,00,000 Cr (FY27)
- Retail Loan Book Growth: 18-20% (FY27)
- Return on Assets (ROA): 2.4-2.5% (FY27)
- Net Interest Margin (NIM): 3.5-3.65% (FY27)
- Credit Cost: -15 to -20 bps (FY27)
- Lead volume: 1.25-1.30 lakh MT (FY27)
- Lead utilization (TKD): 70-75% (FY27)
- Lead utilization (TKD): 80-90% (FY28)
- Copper volume: 12,000 MT (FY27)
- Copper volume: 24,000 MT minimum (FY28)
- Operational centers: 190 centers by Sep-Oct 2026 (FY27)
- Revenue ramp: Full-scale revenue after 3-4 months from rollout (FY27)
- Incremental employees: ~2,000 employees (FY27)
- Margin effect: Temporary margin dip during buildout (FY27)
- Processing charges ratio: 35-38% (FY27)
- Trading volume growth: slightly above India's ~5% electricity demand growth (near term)
- Margin expansion: no substantial increase over the next 2-3 years; only marginal decimal changes
- Short-term mix: medium-term to short-term trades will constitute a larger percentage of volumes (FY27 and beyond)
- NLC JV portfolio: around 2,000 MW initially (initial phase)
- Urja Tista Ram completion: full dam ready by 2029
- Revenue: Record high revenue; substantial disruptive growth (FY27)
- Export revenue: Much higher than Rs 300 Cr (FY27)
- Turnkey revenue: Recover toward last year level (FY27)
- PAT margin: 15% floor (FY27)
- EBITDA margin: 20% floor (FY27)
- Revenue growth: continued growth momentum from AI-led services and larger enterprise engagements (FY2026)
- Adjusted EBITDA margin: sustained high-teens margin through efficiencies and mix (FY2026)
- AI capability build-out: continued investment in AI training, OptimaAI and enterprise AI use cases (FY2026)
- Revenue growth: continued positive growth; no formal numeric guidance (FY26)
- Organic growth: improving from a flat Q1 base as Q2 momentum builds (H2 FY26)
- EBITDA margin: healthy range; roughly 18% to 19% ex-FX commentary (FY26)
- Utilization: rebuild from 80.5% as the AI bench normalizes (FY26)
- AI-enabled revenue mix: increase from the current 29% mix as Execo traction scales (FY26)
- New product introductions: 0 (FY26)
- Soliqua public-sector rollout: new (FY26)
- Toujeo public-sector expansion: new (FY26)
- LANDMARC publication: new publication (FY26)
- NLEM partner revenue growth: volume growth plus WPI-linked pricing (FY26)
- New music content budget FY27: Rs 300–350 Cr (FY27)
- Music vertical revenue CAGR: 20–23% (Medium-term (3–5 years))
- Consolidated company PBT growth: Expected to double (3–4 years)
- Music vertical EBITDA margin: 60–65% (Medium-term)
- Music net margin expansion: 300–500 bps improvement (3–5 years)
- Legacy OE growth: 10-11% run-rate (near term)
- Export growth: retain current level; recover as new customers ramp (FY27-FY28)
- Hybrid program launches: production starts in 2029-30
- Subsidiary EBITDA margin: move toward standalone levels (< 3 years)
- Motors/controllers EBITDA: EBITDA positive and scaling (FY27-FY28)
- Pharma, food and nutrition growth: faster than FY26's 10% growth (FY27)
- Specialty ingredients growth: similar to the last 2-3 years' growth trend (FY27)
- EBITDA margin: 37-38% (FY27)
- Bisglycinate revenue contribution: meaningful contribution (FY28 onward)
- Core business revenue capacity: Rs 1,000-1,200 Cr without incremental capex (post greenfield)
- Summer sales window: 4-6 weeks of decent summer sales (Q1 FY27)
- North India season start: current week to second/third week of May (Q1 FY27)
- Gross margin impact: few points here and there (Q1 FY27)
- Cost pass-through: entire price increase passed on (from Jul 2026)
- BISP EBITDA margin: high single digit, with potential to match air cooler business (medium term)
Phosphate Co (PHOSPHATE) reported its Q3 FY26 standalone financial results, showing a significant sequential increase in revenue and profitability compared to the previous quarter. Revenue: Rs 70.95 Crores, representing a 32.1% YoY growth,.
- Revenue growth: Outgrow the market; no percentage guidance provided (FY27)
- Price hike pass-through: Remaining cost increases to be passed on over the next 2 quarters (Q1-Q2 FY27)
- EBITDA margin: Healthy margins expected, supported by pass-through and continuous improvement; no numeric guide (FY27)
- Bharuch utilization: Above 70% by July (July FY27)
- Jamshedpur first rail bearing: By November-December (FY27)
- Focus Vertical AUM Mix: 85% (FY29)
- Return on Assets (ROA): 3.0% - 3.5% (FY29)
- Annualized Cost Takeout: Rs 220 Cr (FY27)
- Credit Cost: ~2.0% (Next 2 years)
- Embedded Finance GNPA: 4.0% - 4.5% (Steady state)
- FY27 revenue growth: in line with FY26 growth (FY27)
- Q1 FY27 revenue trend: in line with Q4 FY26 (Q1 FY27)
- 2H FY27 vs 1H FY27: 2H stronger than 1H (FY27)
- North America small ag growth: about 5% growth (FY27)
- Europe small ag growth: modest growth, stronger in 2H (FY27)
- Volume growth: 6-7% (FY27)
- Category growth: high single digit (FY27)
- Revenue growth: double-digit (FY27)
- Cost impact: Rs 400-500 Cr (next 2-3 quarters)
- Mitigation plan: Rs 200-250 Cr (already in execution)
- Same-store sales growth: late single digit to double digit on a normalized base (FY27)
- Same-store sales growth: early double digit (FY27)
- Revenue growth: 20-25% (FY27 full year)
- Gross margin recovery: 100-150 bps (FY27 vs Q4 FY26)
- Gross margin band: 67-68% (medium term)
- Revenue growth: 9-11% (FY27)
- Revenue growth: 10-12% in INR (mid-term)
- US and UK revenue growth: double-digit growth (mid-to-long run)
- EBITDA margin improvement: 50-100 bps (FY27)
- Gross margin trend: further expansion (FY27)
- Revenue growth: low-teen growth (FY27)
- EBITDA growth: high-teen growth (FY27)
- Occupancy: 75% (medium term)
- Capex: ~Rs 1,000 Cr (next 3 years)
- Whitefield AC by Marriott completion: Mar 2027
- Volume growth: 6-7% (FY27)
- Sequential quarterly volume growth: about 2% (FY27)
- April volume growth: 8% YoY (April FY27)
- EBITDA margin: around 20% level (FY27)
- EBITDA margin: 21%+ (run-rate / near term)
- FY27 revenue: No explicit numeric target; management expects better performance if macro conditions stay stable and Chennai contributes for a full year. (FY27)
- EBITDA margin: Around 40% after 1-2 years (next 1-2 years)
- Chennai depreciation: 45-50 Cr annualized (FY27)
- Sustaining capex: 35-40 Cr (FY27)
- Large capex: No large capex planned this financial year (FY27)
- Seasonal brand growth: Recovery from May onwards (Q1/Q2 FY27 season)
- Seasonal portfolio growth: Consistent double-digit growth (3-4 years)
- Comfort Click growth trajectory: Continue building momentum across Europe and new geographies (medium to long term)
- EBITDA margin: 17-18% (next couple of years)
- Operating leverage: Should play out on the core business ex Comfort Click (next couple of years)
- Express business growth: Much better growth than the year gone by (FY27)
- Q1 FY27 performance: Very optimistic numbers (Q1 FY27)
- EBITDA: Grow faster than revenue in coming quarters (Coming quarters)
- PBT: Grow faster than revenue in coming quarters (Coming quarters)
- Additional warehouse space: 0.5 million sq ft addition (Next year)
- EBITDA margin: north of 21% (FY27)
- US business revenue: $2 billion near term (next 1-2 years)
- Europe revenue growth: minimum double-digit (FY27)
- Europe and growth market product count: 7-8 products (by 2030)
- US biosimilar product count: 2-3 products (by 2030)
- Topline aspiration: Rs 4,000-5,000 Cr (4-5 years)
- Export contribution: larger than current contribution (4-5 years)
- Phase 1 capacity completion: end-Dec-26 (FY27)
- Next capex phase timing: next 6-18 months (FY27-FY28)
- FY26 capex spend: Rs 70+ Cr (FY26)
- Revenue growth: High single-digit to low double-digit (3-5 years)
- H2 FY26 revenue growth: Mid-single-digit likely; no blowout expected (H2 FY26)
- Profitability improvement: +100 bps from FY24-25 base (next 2-3 years)
- BICOTA / Camalus: Already in market and expected to keep contributing (FY26 onward)
- Xivana Smart: Expected beginning of next year, subject to MRL clearance (early FY27)
- Volume Growth FY27: Fairly decent growth expected; likely to moderate from FY26 11.8% due to inflation headwinds (FY27)
- Value Growth FY27: Significantly higher than volume growth due to 11-12% cumulative price increases (FY27)
- Gross Margin FY27: Expected to hold at current levels despite timing lag between price increases and RM cost absorption (FY27)
- Operating Margin (EBITDA) FY27: 15-17% guided range maintained (FY27)
- Cumulative Price Increases FY27: 11-12% across product mix (FY27)
- Core market growth: 13% plus/minus (FY27)
- Focus market growth: above 20% (FY27)
- UP growth: 20% (FY27)
- Advertising spend: 2% of sales (FY27)
- Gross margin: maintain current gross margin (FY27)
- Total Revenue: 1900-1950 crore (FY26)
- Benzene Business Top Line: 100 crore (FY26)
- Benzene Business Top Line (Full Capacity): 300 crore (Next Year (FY27))
- EBITDA Margin: 11-12% (FY26)
- Blended EBITDA Margin: 13-15% (Normal Market Scenario)
- Q1 FY27 Revenue: Low point for both revenue and EBITDA (Q1 FY27)
- H2 FY27 Growth: Growth returning from H2 FY27 onwards
- Order Conversion: Execution on existing programs and customer conversions to drive recovery (FY27)
- Q1 FY27 Gross Margin: 100-150 bps headwind vs FY26 levels (Q1 FY27)
- EBITDA Margin: Improvement in EBITDA should become visible in H2 as volumes recover and product mix normalizes (H2 FY27)
- Growth across segments: Moderate growth (FY27)
- Domestic demand: Robust (FY27)
- Export demand: Difficult to call; cautious due to geopolitics (FY27)
- Current data center node: QSK60 for the next 2 years
- Possible next node: 78L looks more likely (medium term)
- Radio ad demand: Muted in H1; base-effect recovery in H2 (FY26)
- Non-FCT growth: Events, solutions and concerts should drive growth (FY26)
- Radio yields: Stable over the next 2 quarters; price hikes likely in the festive period/H2 (Q1-Q2 FY26 / H2 FY26)
- Profitability focus: Profitable growth over plain volume growth (FY26)
- Platform monetization: Begin monetizing in Q1/Q2 next fiscal (Q1-Q2 FY27)
- Base order intake: Rs 7,000-8,000 Cr (FY27)
- TBCB pipeline: 33 packages under bidding; 21 at 765kV (near term / FY27)
- Export orders: Could exceed last year's Rs 1,200 Cr in Q1 FY27 if the pending US order closes
- EBITDA margin: mid-20s (FY27 and beyond)
- Capex program: more than Rs 10bn (FY26-FY28)
- Revenue growth: double-digit over the next 3 years
- Annual growth assumption: 20% YoY is not the base case (next 3 years)
- EBITDA margin: 15% minimum consolidated margin (medium term)
- EBITDA margin: 16-17% achievable if growth and cost actions accelerate (medium term)
- Heavy engineering facility revenue potential: 700-800 Cr (current facility)
- Bio-based chemicals market penetration: Stronger from this financial year beginning this quarter (FY27 / current quarter onward)
- Specialty-chemicals demand: Uptick in demand this financial year (FY27)
- Ethanol blend pricing: Industry seeks a revision from the Government of India (near term)
- Blend standards: Draft standards for E85 and E100 beyond E20 notified (future)
- Flex-fuel policy: Policy support for flex-fuel cars required to unlock higher blends (future)
- Revenue growth: early double-digit (FY27)
- Animal nutrition revenue growth: double-digit (FY27)
- Crop care recovery: very strong recovery; high-double-digit growth (FY27, with recovery from Q2)
- Oil palm volume growth: early double-digit (FY27)
- Branded foods growth: double-digit (FY27)
- FY27 capex: Rs 2,800 Cr (FY27)
- CCPP commissioning: Synchronization in 3rd week of Jun-26; full-stream / PGT in 3rd week of Aug-26 (Q2 FY27)
- Ammonia expansion: 50 KTPA coming up next year (FY27)
- Weak nitric acid III: 200 KTPA coming up next year (FY27)
- Ammonium nitrate II: 163 KTPA coming up next year (FY27)
- ETR: around 22% (FY27)
- EBITDA: ₹3,000 Cr (FY30)
- Integration timeline: 18-24 months (next 18-24 months)
- Additional transaction expenses: likely in Q1 (Q1 FY27)
- Patient footfalls: expected to improve in coming quarters
- Cement demand growth: about 6% (FY26-FY27)
- FY26 volume growth: 5.5%-6.5% (FY26)
- Energy cost increase: at least Rs 300/ton (coming quarters)
- Packaging cost increase: Rs 80-100/ton (coming quarters)
- Q1 cost hit: Rs 100-130/ton (Q1 FY27)
- Domestic revenue growth: 8-10% (FY27)
- Export revenue growth: 15-20% (FY27)
- Export revenue mix: 40-45% of value sales (FY27)
- EBITDA / operating margin: 25-30% (FY27 and beyond)
- Global-location capex: Rs 300 Cr (Next 2 years)
- FY27 revenue growth: Double-digit growth (FY27)
- Annual guidance timing: To be shared in Q2 conference call (Q2 FY27)
- EBITDA margin including other income: Around 20% (FY27)
- Price increase pass-through: 6-8% price hikes already taken (FY26-FY27)
- EBO openings: 40-45 stores, possibly 50 (FY27)
- Overall revenue growth: Double-digit (FY27)
- Specialty capacity utilization: About 80% (FY27)
- EBITDA margin: 30% +/-1-2% (FY27 full year)
- R32 capacity expansion: 15,000 MTPA (Q3 FY27)
- DHED debottlenecking: Commissioning in Q3 FY27
- Revenue CAGR: 18-20% (5-year horizon)
- Growth visibility: Visible growth over the next 2-3 years
- Quarterly progression: Not every quarter will show progression; 10-12 quarter trend should reveal the underlying growth line (next 2-3 years)
- ROCE: Expected to moderate as capital deployment cycles lengthen (as capex ramps)
- Peptide facility commercial benefit: At least a few years (post-July commissioning, multi-year horizon)
- Net interest margin: 6.5% for the upcoming financial year (FY27)
- AUM: Double over the next 3 fiscal years
- Income: Double over the next 3 fiscal years
- Net profit: Double over the next 3 fiscal years
- Co-lending structure 1: Go live this quarter (Q1 FY27)
- Mexico Plant Production Start: Mid-FY26
- Revenue Growth: Healthy growth supported by India and Exports (FY26)
- Europe demand: Gradual incremental growth (Coming quarters)
- Domestic demand: Gradual incremental growth (Coming quarters)
- US demand: Flat / straight curve (Coming quarters)
- EBITDA margin: Product-mix-led improvement; no numeric target disclosed (FY27)
- Gross margin: Supported by mix and quarterly pass-through; expected to remain resilient (FY27)
- Revenue from operations: Rs 6,200-6,500 Cr (3-4 years)
- EBITDA margin: Double-digit EBITDA at the earliest (near term)
- EBITDA uplift from knitting expansion: 3-4% improvement (post commissioning)
- Knitting capacity: 900 MT/month from 600 MT/month (Q3 FY26)
- B2B / rPET project capex: Rs 427 Cr (FY27 Q1 operation target)
- Consolidated revenue growth: ~15% (multi-year)
- ROE / return profile: ~15% (multi-year)
- Security Solutions growth: 11%-12% (sustainable annual run-rate)
- Facility Management growth: 12.5%-15% (sustainable annual run-rate)
- International growth: ~7.5% (sustainable annual run-rate)
- Revenue run-rate: 100 Cr per quarter (FY27)
- Revenue uptake: Should start by middle of the year as implementations close (FY27)
- Quarter-to-quarter conversion: Expected to improve quarter by quarter (FY27)
- R&D intensity: 12%-15% of overall cost (FY27 framework)
- Engineering cost: Lower through AI-assisted development and faster releases (FY27)
- Net margin after tax: 5% (medium term)
- Current export growth: 10-20% (current exports / industry)
- Target export geographies: Malaysia, Vietnam and African countries (medium term)
- Capacity expansion: 30-40% (medium term)
- FDY capacity expansion: 30,000 TPA (medium term)
- Volume growth: 15% per annum (FY27 and beyond)
- Composite product growth: above 25% (next 3 years)
- Company revenue scale: more than $1 billion business (next 5 years)
- EBITDA growth: over 2% above volume growth (FY27)
- PAT growth: minimum 21% (FY27)
- Market growth: close to mid-single digit (FY27-FY28)
- Company growth: ahead of the market (FY27-FY28)
- Wires contribution: strong growth driver (next few quarters)
- Consumer Products momentum: much better than the current quarter (next 12 months)
- Lighting EBIT / debit-level margin: close to current levels (FY27)
- Walls segment revenue growth: Double-digit growth trajectory sustained (FY27)
- Construction Chemicals revenue growth: Scalable, profitable growth (FY27 onwards)
- Pipes segment recovery: Strong momentum with improved realization and volume growth (FY27)
- Parador revenue: Gradual recovery through deeper retail penetration and new market traction (FY27)
- Consolidated EBITDA margin: Double-digit EBITDA margin aspiration (FY27 onwards)
- Room Air Conditioner Industry CAGR (2030): 18% to 20% (by 2030)
- Room Air Conditioner Industry Units (2030): 40 to 50 million units (by FY30)
- Primary Sales Growth (Q1 FY27): 25% to 30% (Q1 FY27)
- Commercial Air Conditioning & Electromechanical Projects Growth: 8% to 10% (FY27)
- Segment 1 Operating Margin (Electro-mechanical projects and Commercial AC): 7% to 7.5% (near term)
- Sales Growth: Stronger than FY26 (FY27)
- EBITDA Margins: Managed within a certain band (FY27)
- Domestic Market Stability: Stabilized (End of current quarter)
- International Business Performance: Better (Current quarter)
- New Platforms: Adding more (Future)
- Export volumes: Business should keep growing; stuck Q4 containers are expected to execute in Q1 and the Saudi importer could add 30,000-40,000 tons over time. (Near term / FY27)
- Domestic sales: Domestic visibility should improve after distributor tie-ups and e-commerce expansion. (FY27)
- Profitability: Similar profitability is expected in future quarters. (Near term)
- Freight and insurance costs: Buyer pass-through should continue to offset war-related freight and insurance pressure. (Near term)
- New unit utilization: 3 installed units should keep scaling from about 50% efficiency. (Near term)
- EBIT margin: Should go back up once war-driven turbulence settles (near term)
- Solar portfolio revenue: Rs 2,000 Cr business (next 3-4 years)
- Residential wires rollout: Ramp throughout the country; not restricted to select towns/cities and not stretched over the full year (near term)
- Rion launch: Products to come into the market soon (near term)
- Revenue growth: Low to mid teen growth (FY27)
- Domestic industry growth: 8% to 9% (FY27)
- EBITDA margin expansion: 75 to 100 bps (FY27)
- Gross margin: Around 60% (FY27)
- Europe business CAGR: Mid-teens CAGR (Next 2 years)
- Constant-currency revenue growth: 10%-13% (FY27)
- Revenue phasing: Evenly spread across 4 quarters (FY27)
- EBIT margin: 12.25%-12.75% (FY27)
- Inorganic growth contribution: 2%-2.5% (FY27)
- Effective tax rate: 20%-22% (FY27)
- Revenue growth: close to 15% (medium term)
- EBITDA margin improvement: additional ~100 bps (FY27 / near term)
- Payor mix: favourable by 100 bps over the last couple of quarters
- Beds by FY30: 1,000 beds (FY30)
- Greenfield beds by FY30: 400 beds (FY30)
- Industry volume growth: High single digit (FY27)
- Scooter growth vs motorcycles: Scooters to grow a couple of points more than motorcycles (FY27)
- Hero volume growth: Outgrow the industry (FY27)
- Half-year growth profile: H1 stronger than H2 due to base effect (FY27)
- EBITDA margin: 14% to 16% (Medium term / FY27)
- Home Appliances Division Revenue CAGR: 20%+ over 3 years (FY26-FY28)
- AC Market Share: 3% to 6% (FY26)
- Appliances Division EBITDA Margin: Double-digit (10%+) (FY26-FY27)
- Material Cost Savings: Rs 79 Cr full-year (Rs 44 Cr Q4) (FY26)
- Logistics Cost Control: Rs 150-175 Cr reduction target (FY26-FY27)
- Standalone volume: >250 mmscm (FY27)
- Volume growth: 30%+ (FY27)
- Segment growth: >20% YoY across all 4 segments (FY27)
- Gross margin: 25-26% (FY27)
- EBITDA per SEM: Rs 5.3-5.5 (next FY)
- Revenue from operations growth: 15% (FY27)
- Revenue from operations: Above Rs 6,500 Cr (FY27)
- EBITDA margin: 14-15% (FY27)
- EBITDA margin target: 15-16% (medium term)
- PAT margin: Around 7% (FY27)
- Revenue: Rs 1,500 Cr (FY28)
- Operating margin: 17-18% (FY28)
- Gross margin: 42% (near term / ongoing)
- Brand spend: 5-7% of sales (2-3 years)
- EBITDA margin: 17-18% (FY28)
- Domestic demand: Strong through the summer season (Q1 FY27)
- International demand: Still pressured by Middle East situation, higher fares and route curtailments (near term)
- Overall growth base: Q1 FY27 starts against a lighter base than Q4 FY26
- Train growth: Near-term headwinds likely until policy changes stabilize (FY27)
- PRS rollout: Upgraded PRS expected later this year, around Aug/Sep (late FY27)
- U.S. business revenue: sustain USD 1bn+ revenue (next 2-3 years)
- India formulations growth: 20-30% ahead of the market (next few years)
- India RX growth: double-digit growth (next few years)
- Other developed markets contribution: increase after Visu Pharma closes (FY26-FY27)
- EBITDA margin: 27-28% (FY26 full year)
- AUM growth: 12-15% (FY27)
- AUM: Rs 30,000 Cr (FY30)
- Lives touched: 10 million (FY30)
- JLG mix: 53% (FY30)
- Non-JLG mix: 47% (FY30)
- Revenue guidance: No formal FY27 guidance; revisit after Q1
- EBITDA margin guidance: No formal FY27 guidance; possible pressure from inflation and logistics
- Order inflow guidance: No formal FY27 guidance across order inflow parameters
- FY27 capex: Rs 500 Cr (FY27)
- Mining equipment capex: Rs 100-150 Cr (FY27)
- CPC and CTP demand: Steadily increasing (next 3-5 years)
- Carbon segment volume: Stable (balance of 2026)
- Advanced Materials sales exposure to West Asia: No material impact expected (FY26)
- Cement segment performance: Gradual recovery (FY26)
- Carbon margins: Normalised margins (FY26)
- Revenue growth: 15-20% (next 3 years)
- EBITDA margin: 28-30% (next 3 years)
- Capex spend: ₹1,100-1,300 Cr (FY27)
- Capex mix: 65% CDMO / 35% CRO (FY27)
- Capacity allocation: 75% toward capacity expansion (FY27)
- Gross revenue target: US$108bn (Vision 2030)
- Dividend payout ratio aspiration: up to 40% (Vision 2030)
- FY27 capex: Rs 6,000 Cr +/-10% (FY27)
- Growth capex mix: 50% (FY27)
- Maintenance capex mix: 50% (FY27)
- EBITDA margin: Improvement quarter-on-quarter (Q4 FY26 onward)
- Operating benefit from cost actions: Real benefit in about 2-3 quarters (next 2-3 quarters)
- Q4 performance versus Q3: Q4 should be better than Q3 (Q4 FY26)
- Top line: Higher even at similar volumes through product upgrades (FY26)
- Home textile share of topline: 20% of total topline (medium term)
- Revenue growth: 15%+ (FY27)
- Volume growth: 10-11% (FY27)
- Q1 FY27 growth: high-single-digit (Q1 FY27)
- EBITDA margin expansion: 100-150 bps (FY27)
- Overall price hike impact: 12-15% (FY27)
- Hubs added: 4-5 hubs (FY27)
- Spokes added: 10-12 spokes (FY27)
- Capex for new centers: Rs 120-130 Cr (FY27)
- Automated lab capex: Rs 140-150 Cr (FY27)
- Replacement capex: Rs 10-12 Cr (FY27)
- Revenue growth: 15-18% over the next 3-4 years
- EBITDA growth: 15-18% over the next 3-4 years
- CDMO/CMO sales growth: 40-50% per annum (FY27)
- Xanthine sales potential: well beyond Rs 1,000 Cr (current expansion cycle)
- EBITDA normalization: at least 1 year for current capex to meaningfully contribute (next 12 months)
- Consolidated sales growth: 4% to 4.5% (FY27)
- Comparable consolidated sales growth ex Fasca Zirconia, Avoco and Kumi Avoco: 11% to 12% (FY27 vs FY26 adjusted base)
- Consolidated abrasives sales growth: 5.5% to 6% (FY27)
- Consolidated abrasives sales growth ex Avoco: 11% to 12% (FY27 vs FY26 adjusted base)
- Consolidated ceramic sales growth: 15% to 15.5% (FY27)
- Overall Revenue Growth: 18-20% (FY27)
- Sanitaryware Volume Growth: 7-8% (FY27)
- Faucetware Volume Growth: 10-12% (FY27)
- Revenue from Senator and Polyplus: 70-80 crores (FY27)
- EBITDA Margin: 14-15% (Full Year)
- Overall revenue growth: 18-20% (FY27)
- Domestic institutional and export growth: good growth (FY27)
- EBITDA margin improvement: 0.5-0.75 percentage point improvement (FY27)
- EBITDA margin: double digits (next 2 years)
- Herbicide facility commissioning: Q3 FY27
- Delhi NCR revenue growth: 25-30% growth from the current ~Rs 590 Cr base (FY27)
- Delhi NCR revenue base: Rs 590 Cr base (FY26)
- Delhi NCR EBITDA margin: 2.5-3.0% (FY27-FY28)
- Delhi NCR EBITDA margin: 3-4% higher than the current level (FY28)
- Store additions: Around 20 odd stores this year across existing older clusters (FY27)
- Core gases revenue contribution: main growth and profit driver (FY26)
- Project engineering revenue contribution: lumpy / periodic (FY26)
- Like-for-like sale of gases growth: nearly 10% YoY (Q2 FY26 run-rate)
- EBITDA margin: improve further from 37% base as production ramps (FY26)
- Argon revenue share: increase further with higher production (FY26)
- Consolidated revenue growth ex new acquisitions: 23% YoY (FY27)
- Like-for-like revenue growth: ~15% YoY (FY27)
- EBITDA margin: 5% (FY27)
- EBITDA to operating cash flow conversion ratio: at least 50% (FY27)
- Minority interest contribution as % of PAT before MI: 25-27% (FY27)
- Net usable iron ore: 3.4 MnT (FY27)
- Actual iron ore mining: 4.0-4.25 MnT (FY27)
- Iron ore mining capacity: 6.0 MnT (FY28)
- Usable iron ore after beneficiation: 4.5 MnT (FY28)
- Landed ore cost: Rs 3,000-3,200/t (FY27)
- EBITDA margin: Lower than normative in Q1 and probably Q2; pressure expected this quarter and next (Q1-Q2 FY27)
- Gross margin: Slightly lower than Q1 (Q1 FY27)
- India revenue growth: Higher revenue growth than Q4 FY26 in FY27
- India EBITDA margin: Normative EBITDA margins over time (FY27 onward)
- Volume growth: Mid-single-digit (FY27)
- Incremental revenue: 330-350 Cr (FY27)
- Core market incremental revenue: 170-180 Cr (FY27 annualized)
- Focus state incremental revenue: 125-130 Cr (FY27)
- Other states, e-commerce, railways and modern trade incremental revenue: 35 Cr (FY27 annualized)
- Gathiya growth: 18-20% (FY27)
- Aluminium cost inflation: About 5% increase over Q4 FY26 (Q1 FY27)
- Oswego hot mill restart: In the next few weeks (Q1 FY27)
- Novelis adjusted EBITDA per tonne: $600/ton long-term (Long term)
- Novelis exit savings run-rate: $200m run-rate now; $350-$400m by FY28 exit (FY27-FY28)
- Bay Minette ramp: 18-24 months to full run-rate; EBITDA/ton north of $1,000 at steady state (FY28)
- Capex program: Rs 4,000 Cr total; Rs 2,000 Cr announced in Oct 2024 already on the ground (multi-year / through 2028)
- Incremental transformer capacity: 30-40 GVA (post-capex buildout)
- Transmission pipeline: Largest in the order book; project delays said to be behind (FY27)
- FY27 domestic inquiry pipeline: No quantified guide disclosed (FY27)
- Export share: ~25% of revenue; export orders run on a similar line (FY26 / near term)
- Sales growth from closeout year: 300 Cr (SY27 versus closeout SY26)
- US class 8 sales contribution: 50-75 Cr (FY27)
- Domestic CV market growth: 10% (FY27)
- Interest cost: 55 Cr (Next year)
- EBITDA / PAT: Both should improve (FY27)
- Crude oil production: 3.70 MMT (FY26)
- Natural gas production: 3.65 BCM (FY26)
- Crude oil production: 3.95 MMT (FY27)
- Natural gas production: 4.31 BCM (FY27)
- Oil + oil equivalent production: 7.5 MMTOE (FY27)
- Loan growth: around 10% (FY27)
- Prepayment pressure: should moderate (FY27)
- Spread: 2.4 to 2.5% (FY27)
- Merged entity formation: by 1 Apr 2027 (Medium term)
- Government company status: to be maintained post-merger (Post-merger)
- Credit growth: 13-15% (FY26)
- Corporate credit growth: double-digit (Q4 FY26)
- RAM contribution: significant contribution (Q4 FY26)
- Exit net interest margin: about 3% (FY26 exit)
- Long-term net interest margin: around 3% through cycles
- Truck AC revenue: Rs 325-350 Cr (FY27)
- Railway order book: Rs 52 Cr (Subsequent quarters)
- E-compressor annual revenue potential: Rs 250 Cr per year (Medium term / post-commissioning)
- EBITDA level: Current level with some moderation / improvement / rationalization (FY27)
- EBITDA margin: 2-digit long-term target intact (Long term)
Suncare Traders (SCTL) reported a net profit of Rs 1.32 Crores for Q4 FY26, despite recording zero revenue from operations during the quarter. The company's profitability was driven by non-operating income rather than core business activities.
- Revenue growth: 15-20% CAGR (3-5 years)
- FY27 revenue guide: No specific FY27 guidance provided
- EBIT margin: No formal target; sustainability easier if gold remains at current rate (FY27 / near term)
- Margin pressure: 10-20 bps drag currently visible; offsets via 18K/14K, lightweight jewellery and overhead control (current run-rate)
- LGD4A store count: 10-12 stores across 2-3 cities (near term / before national launch)
- Data center and cloud revenue: Rs 1,200 Cr (FY27)
- Data center and cloud revenue: Rs 9,000 Cr (FY32)
- IT load capacity: 63 MW (by Dec-26 / FY27)
- IT load capacity: 117 MW (FY28)
- IT load capacity: 307 MW (FY32)
- Domestic OE growth: 10-11% (near term)
- Export revenue: retain last year's level, with upside as new products ramp (FY27)
- EV penetration: 15-17% (2030)
- Overall vehicle volume CAGR: 6% (next 4 years)
- Subsidiary margins: close to standalone margins (2-3 years)
- Revenue from operations: Add 30%-35% to existing revenue numbers (post-ramp / next phase)
- Incremental topline from expansion: More than Rs 1,000 Cr (post-commissioning)
- Yarn turnover uplift from price normalization: 5%-7% of existing turnover (near term)
- EBITDA margin: 16%-20% (current year / normalized)
- Fabric margin profile: Superior to yarn margins (cycle)
- Revenue growth: Double-digit growth (FY27)
- Handover activity: Accelerate over the next few quarters and keep increasing through FY27-FY29
- Mature store revenue growth: 10%-15% (Going forward)
- Store ROI: About 3 years (Current model)
- Store format mix: Transition from furniture brand to complete home solution provider (FY27 and beyond)
- Overall business growth: double-digit growth (FY27)
- Business mix: all 3 businesses to contribute to growth (FY27)
- EBITDA margin: no specific guidance; improvement remains structural (FY27)
- Quarterly volatility: may continue due to industry dynamics (FY27)
- SMT utilization: expected to grow from 30-40% (FY27)
- Revenue growth: High single-digit growth (FY27)
- Domestic automotive / industrial growth: High single-digit growth (FY27)
- EBITDA margin: 13-14% (medium term)
- Price increase: Another 2-3% may be needed (coming periods)
- Operating margin: 6-7% initially (initial ramp-up)
- Margin profile: very steady over the next 5 years or so
- Order book: very good; every major OEM project through 2031 is covered
- Capacity utilization: current location is near max-out; enlargement needed (near term)
- Capital expenditure intensity: 1.5% to 3.5% of total net sales (ongoing)
- Vehicle content per vehicle: continuous increase through 10th-gen ESP and new braking systems (medium term)
- Overall revenue growth guidance: 15-20% (FY27 / near term)
- India revenue target: Rs 500 Cr (within 5 years)
- Surface business growth: 7-8% landing / 10% target (next year)
- EBITDA margin guidance: 18-20% (FY27)
- Gross margin on kitchen faucets/appliances: 50-60% (medium term)
- Consolidated revenue growth: 12-13% constant-currency growth (FY27)
- Medium-term CAGR: 15% CAGR (next 3-4 years)
- Base business EBITDA margin: 33-35% (FY27)
- Consolidated EBITDA margin: 25-26% (FY27)
- Cenexi EBITDA: mid-single-digit to high-single-digit EBITDA by end of FY27; mid-teen EBITDA in the medium term (FY27 / medium term)
- Sales volume growth: At least 21% (FY27)
- EBITDA per ton: Rs 65,000-70,000 per MT (Long term)
- EBITDA per ton: Rs 67,000-74,000 per MT (FY27-28 / near term)
- Next capacity tranche commissioning: Q2 FY27
- Installed capacity: About 59,000 MT (FY27)
- FY26 dividend per share: Rs 30/share (FY26)
- Buyback: Not at this point (near term)
- Special dividend: No comment / not specified (near term)
- HSBC principal amortization: 5% every year for 5 years, then 75% bullet in year 6 (from May 2027)
- Debt repayment from surplus cash: No concrete plan (near term)
- Commercial start of Topcon line: By Feb 2027
- Ramp to full utilization: About 2 months after commercial start (2 months post-commissioning)
- Cell efficiency on upgraded line: >24.5% (post-commissioning)
- Phase III solar cell capacity: 2 GW by June 2027
- Phase IV solar cell capacity: 2 GW by June 2028
- ZBM store count: 800-850 stores by quarter-end (near term)
- ZBM network coverage: 75-80% of the network (near term)
- Franchise store count: close to 1,000 stores (next 12 months)
- Blended raw-material inflation: 5-6% (near term)
- Pricing action: dynamic price elasticity as needed (near term)
- Morbi gas sales volume: 8.8-8.9 mmscmd (near term)
- Current Morbi gas sales volume: close to 8 mmscmd (current run rate)
- Morbi contract tenor: 1 month (current arrangement)
- Gas trading margin: 4.4%-6% (near term)
- Gas trading volume growth: 25%-30% (by FY31)
- Revenue growth: decent growth (upcoming season / FY27)
- Herbicide segment growth: good increase (FY27)
- EBITDA margin: small increase (FY27 / upcoming season)
- Top line and bottom line: both positive (FY27)
- FY26 capex: around Rs 100 Cr (FY26)
- FY27 consolidated revenue guidance: Rs 875 Cr (FY27)
- PAT margin guidance: 12-13% (FY27)
- Gross margin guidance: 50-55 (FY27)
- FY27 India capex guidance: Rs 15-16 Cr (FY27)
- Manufacturing capacity target: Rs 1,500 Cr+ (after Houston and Saudi plants / FY31 target)
- Revenue CAGR: 15%-20% (3-4 years)
- Annual revenue guidance: No annual guidance (FY27 onward)
- India gross clinic additions: 40-50 clinics per year (FY27-FY28)
- Philippines roll-ups: 12-15 clinics per year (FY27-FY28)
- Saudi clinic count: Not quantified yet (Next few quarters)
- Store count: 4 stores in calendar 2026 (Calendar 2026)
- Surat and Rajkot openings: Q2 FY27
- Gandhinagar and Maninagar openings: Within this calendar year / season time (Calendar 2026)
- Daily-wear in-house production: Commence from Q1 FY27
- B2B daily-wear pilot: Launch a few varieties and test market response at IIJS (FY27)
- Layer chick sales volume: 5 crore+ chicks (FY27)
- Broiler chick volume growth: 4-5% growth (FY27)
- Commercial broiler / CBF volume growth: 2-3% growth (FY27)
- Poultry industry growth: 7-8% growth (FY27)
- Animal health revenue growth: double-digit growth (FY27)
- Consolidated revenue growth: High-teens growth (FY27)
- North America revenue growth: Single-digit growth (FY27)
- India growth vs IPM: 200-400 bps above IPM (FY27)
- International markets growth: 40%+ growth continues (FY27)
- Consumer wellness growth: Double-digit growth (FY27)
- Cost-to-assets ratio: Improvement on full-year basis (FY2027)
- Volume Growth: 6-7% (FY27)
- Cost Pressure: Rs 70-80 per ton increase (Q2 FY27)
- Annual Capex: Rs 900 Cr (FY27)
- Net Debt: Rs 2,000 Cr (FY27)
- OSAM gross margin: 25% soon (near term)
- Grammage reduction: limited (near term)
- Milk growth: around 4.5% (current scenario / near term)
- VAP growth: significantly higher than liquid milk (near term)
- Procurement cost: no sequential increase through mid-May; reductions may begin end-May (end-May / near term)
- Credit Cost: 1.7% to 1.9% (FY27)
- Gross NPA: Sub 3% (FY27)
- Incremental Cost of Funds: 8.5% (FY27)
- Net Interest Margin: 5.8% (FY2027)
- Credit Cost: 150-160 bps (FY2027)
- Cost-to-Income Ratio: Below 70% (FY2027)
- VNB Growth: No specific guidance (FY2027)
- Cost-to-average AUM: 4% or below (End of FY2027)
- OPEX reduction: 25 bps reduction (FY2027)
- Credit cost: 1.4% - 1.5% (Next 2 quarters)
SKP Securities (SKPSEC) reported strong financial performance in Q4 FY26, characterized by double-digit revenue growth and significant margin expansion on a standalone basis. Growth Dynamics: The company delivered a 27.2% YoY increase in revenue.
- Revenue Growth: Net positive financial year (FY27)
- Gross Margin: Stabilize at 65-65.5% (FY27)
- FY27 product-order execution: around Rs 1,000 Cr (FY27)
- Order book target: around Rs 3,000 Cr at some point (FY27)
- Pipeline size: few thousands of crores (FY27)
- Delivery window: Q2 and Q3 FY27
- First-quarter order wins: some orders in Q1 FY27
- Revenue CAGR: 20% (5 years)
- Closing AUM: Rs 1,250-1,300 Cr (FY27)
- Overall growth rate: ~35% growth in the next few quarters / current year (FY27)
- Base business growth: 15-20% (FY27)
- Skid assemblies contribution to business: 20-22% of total business (FY27)
- EBITDA margin: around 23% (FY27)
- EBITDA margin: around 25% annually (next couple of years)
Asi Industries (ASIIL) reported Q4 FY26 standalone results characterized by modest top-line growth alongside significant contraction in profitability metrics. Profitability Pressure: While revenue grew marginally by 1.8% YoY, the company experienced a sharp decline in profitability.
View the company →- FY27 Revenue Growth: Ahead of industry rates by meaningful margin; no specific % provided (FY27)
- Order Book Execution: 68-72% of Rs 1,800+ Cr order book executable in FY27
- Data Center Revenue Recognition: Fairly large chunk of Rs 350 Cr hyperscaler deal within FY27
- EBITDA Margin: Temporary pressure in FY27 from R&D and project investments; no specific target
- Contribution Margins (Transit & Software): Materially improve as proprietary stack ownership expands; end-state margins very strong (Medium-term)
- Revenue target: Rs 3,000 Cr by 2028
- Consolidated volume growth: 10-15% (FY27)
- DME EBITDA margin: 22-23% (near term)
- DME utilization: 30-40% in the current financial year (FY27)
- DME utilization: 50-60% by year-end (FY27)
- Revenue: Rs 5,000 Cr by FY29-30 / 2030
- Revenue CAGR: 20-25% CAGR (next 3-4 years)
- Volume growth: 20% volume growth (FY27)
- Price growth: 5% price growth (FY27)
- EBITDA margin: Around 5% (next year)
- Revenue growth: >15% (FY27)
- EBITDA margin: >28% (FY27)
- Order inflow: >55,000 Cr (FY27)
- QRSM contract: Expected by June end; 5-10% slip risk to July (next 1-2 months)
- First production model: Within 18 months of signing (post-signing)
- Net Interest Margin (NIM): 2.50% - 2.60% (FY2027)
- Slippage Ratio: 0.80% (FY2027)
- Net NPA: 0.40% (FY2027)
- Consolidated AUM: Rs 46,000 Cr (FY27)
- Consolidated AUM: Rs 57,000 Cr (FY28)
- Gold Loan AUM growth: 25–30% YoY (FY27–FY28)
- MSME AUM growth: 20–25% YoY (FY27–FY28)
- Housing AUM growth: 25–30% YoY (FY27–FY28)
- Volume growth: Around 15% (FY27)
- EBITDA growth: Around 15% (FY27)
- EBITDA per kg: Keep per-kg EBITDA broadly stable (FY27)
- Maintenance capex: About Rs 25-35 Cr (Next 2 years)
- Big capex: No big capex planned (Next 2 years)
- FY27 Revenue Growth: Robust growth (no specific % given) (FY27)
- Executable Order Book (12-month): $1.75 Bn (Q4 FY26)
- Large Deals Signed: 21 deals in FY26 (11 in H2); 5 in Q4 (FY26 / Q4 FY26)
- Framework Agreement Revenue (UK Public Sector): $4–5 Mn quarterly base run-rate; material ancillary expansion expected (Starting Q1 FY27)
- Consolidated EBITDA Margin: 20.5–21% (FY27)
- Revenue growth: early to mid-teens (FY27-FY28)
- Organic CAGR: 14%-15% (FY26-FY31)
- FY31 revenue target: ₹8,400 Cr (FY31)
- Inorganic revenue contribution: ₹1,700 Cr (FY31)
- EBITDA margin expansion: 100 bps (exit FY27)
- Revenue CAGR: 15-20% (Next 3-5 years)
- Peak Revenue (New Capex): Rs 1,300-1,500 Cr (Post-commissioning)
- Annual Capex: Rs 400 Cr (FY28)
- Target ROCE: 20% (Medium term)
- EBITDA margin: Breach 8% this year (FY27)
- EBITDA margin: Enter double digits if volume growth, rupee depreciation and energy savings continue (medium term)
- Plant utilization: 75-80% (near term)
- Plant utilization: >95% (next 2 years)
- Incremental product capacity: 40,000 tons (next 5 years)
- Revenue from operations: Rs 5,300-5,400 Cr (medium term / post current expansion)
- Installed capacity: 1.3 mt (current expansion completion)
- EBITDA margin: around 20% (post mine integration / medium term)
- EBITDA improvement per tonne: about Rs 2,000 (once captive mines are operational)
- Capex program: Rs 3,000 Cr (FY27-FY28)
- Volume CAGR: 20-25% (next 3 years)
- FY27 volume growth: slightly above 20-25% (FY27)
- Copper volume growth: 40-50% (this year)
- RML EBITDA per ton: Rs 65,000-70,000 per ton (next 2-3 years)
- Copper business ROCE: 20%+ (next 2-3 years)
- Constant-currency revenue growth: 12.5% (FY27)
- Aspirational revenue growth: 15% (FY27+)
- Operating margin: 17.5-18.5% (FY27)
- Operating margin improvement: about 100 bps (FY27)
- AI/GenAI-focused team: 1,000 people (By end-FY27)
- AUM growth: around 25% YoY (FY27)
- Spread ex co-lending: 5.0% to 5.25% (FY27)
- Cost of borrowing: around last quarter levels in Q1 (Q1 FY27)
- Credit cost: 30 to 40 bps (FY27)
- Branch additions: 30 to 40 branches per year (Annual run-rate)
- Disbursements: Rs 50,000 Cr (FY26)
- Loan book: Rs 1.6 lakh Cr (March 2026)
- Loan book: Rs 3 lakh Cr (FY30)
- Net interest margin: 3.0% to 3.1% (FY26)
- Spread: Around 2% (FY26)
- Order book visibility: Healthy for the next few quarters
- Quantitative revenue guidance: No forward-looking numbers disclosed (FY27-FY28)
- Capex mix: About 70% growth-oriented and about 25% replacement/maintenance (ongoing)
- Maintenance intensity: No structural reset in cost base; maintenance remains manageable (ongoing)
- Dividend payout: Steady and progressive distribution (FY27 onward)
- Revenue growth: 10%-15% (FY27)
- Top-line growth: about 10% (FY27)
- EBITDA margin: similar to current levels / around 11% (FY27)
- Gross margin: 45%-47% (FY27)
- Manufacturing segment EBITDA margin: similar to 12.17% (FY27)
- India caustic soda demand growth: 5% (near term)
- North India demand growth: 4-5% (near term)
- Capacity utilization: 80-95% range, with ~85% at best (next 1 year)
- New North India capacity additions: none expected for 2-2.5 years (next 2 years)
- Caustic soda price versus pre-war: 12-15% higher (current / near term)
- AUM growth: 25-30% annual growth (FY27 onward)
- AUM target: Rs 2,300-2,400 Cr (next year)
- Two-wheeler portfolio share: about 65% (3 years)
- Other products share: about 35% (3 years)
- Karnataka launch: operations to start in Q2 FY27
- Volume Growth: 10-12% (FY27)
- EBITDA per kg: Rs 44-45 (FY27)
- Total Production Volume: 1 lakh tonnes (FY27)
- Revenue Growth: Over 10% (FY27)
- EBITDA per kg: Rs 15 (FY27)
- ROA: Closer to 3% (FY27)
- NIM: 10% (End of FY27)
- Blended Credit Cost: 2.6% to 2.7% (FY27)
- Consolidated revenue: Rs 13,500 Cr (FY27)
- Retail revenue: Rs 9,800 Cr (FY27)
- Gross margin: 12-13% (FY27)
- EBITDA margin: 7-7.5% (FY27)
- PAT margin: 4% (FY27)
- Volume Growth: 18% YoY (FY27)
- Wires & Cables Margin: 10.5% (FY28)
- Total Volumes: around 7 million ton (FY27)
- Volume Growth (AP and Telangana): 5% to 10% (coming year)
- Volume Growth (Tamil Nadu): 5% to 10% (coming year)
- Volume Growth (Karnataka): 5% (coming year)
- Volume Growth (Odisha): 5% (coming year)
- Revenue growth: 50% (FY26)
- PAT growth: 100% (FY26)
- EBITDA margin: about 30% (FY26)
- Regulated market EBITDA margin: around 40%+; improve by about 1% (coming quarters)
- Emerging market EBITDA margin: close to 20% at peak; 18-22% in FY27
- FY27 revenue: Rs 650-675 Cr (FY27)
- FY27 EBITDA margin: 18-20% (FY27)
- New MCC facility utilisation: about 30% in Q1 FY27, 40-50% in Q2 FY27, higher thereafter
- Business normalcy: complete normalcy by FY27 or mid FY28 (FY27-mid FY28)
- MCC capacity addition: 12,000 MTPA at Dahej (by Q4 FY27)
- Revenue outlook: Cautiously optimistic (FY27)
- Q1 FY27 demand: Constructive (Q1 FY27)
- H2 FY27 visibility: Depends on monsoon outcomes and global dynamics (Q2-H2 FY27)
- Price actions: 15 Mar, 1 Apr, 1 May and potentially 1 Jun hikes (Q4 FY26 to Q1 FY27)
- Margin stance: Sustainable margins (FY27)
- Volume growth: 8-10% (FY27)
- Normalcy timing: By June-end; Q2 onward normal (FY27)
- Company capex: Around Rs 250 Cr (FY27)
- EPS capacity: 115,000 TPA (Post-Apr 2026 commissioning)
- ABS utilisation: 80-90% of current arranged capacity (FY27)
- Advances Growth: 21-22% (FY27)
- Deposit Growth: 18% (FY27)
- Total Business Growth: 20% (FY27)
- Net Interest Margin: >4% (FY27)
- Return on Equity: 15% (FY27)
- Soda Ash Export Pricing: 160-180 FOB (Near term)
- Annualized Capex: Below depreciation (FY27)
- Capex: Rs 25,000 Cr (FY27)
- IPP renewable commissioning: ~2 GW (FY27)
- Solar commissioning mix: 1.5-1.8 GW (FY27)
- Renewable pipeline completion: 50% of ~5 GW by FY27; balance by FY28 (FY27-FY28)
- Rooftop solar growth: 50-60% (FY27)
- NEC massive MIMO revenue: Revenue expected in FY27
- South Asia 4G expansion revenue: Some revenue already booked; more expansion expected during FY27
- International wireless funnel: Substantial opportunities expected to order and book revenue in the coming year (FY27)
- PAT: Goal is PAT positive (FY27)
- Overall financial results: Better financial results expected on current investments and cost control (FY27)
- FY27 volume growth: high single digit to low double digit (FY27)
- Volume growth: double digit growth (next couple of years)
- Volume CAGR: double digit CAGR (next 3 years)
- Consolidated EBITDA margin: 16% to 18% (next 24 to 36 months)
- Q1 margin profile: input-cost pressure expected (Q1 FY27)
- Volume growth: 10-12% (next 2-3 years / FY27)
- Operating EBITDA margin: ~20% range (FY27 and beyond)
- Capex: Rs 300 Cr (next 2 years)
- Incremental rope capacity: +6,000 tons (next 2 years)
- Plasticated LRPC capacity: 6,000 tpa; step-up to 8-9k later (next 2 years)
- Revenue growth: double-digit growth over successive years (5-year view)
- Export growth: growth in FY27, with more growth in FY28 (FY27-FY28)
- EBITDA margin: double-digit EBITDA in 1-2 years
- Return on sales: 18%+ (medium term)
- Return on equity: 15%+ (medium term)
About the results calendar
Indian companies typically announce quarterly results a few days after the board meeting date shown here. This calendar lists who is reporting and, where we have prior-quarter coverage, last quarter's reported numbers and — where available — what management said and guided, a pre-read for the numbers to come.
Recaps are factual summaries of what was reported and guided, drawn from the company's own earnings materials. They are informational only.